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PART ONE 
INTRODUCTION AND REVIEW OF THE LITERATURE 
A. PURPOSE 
In several recent biochemical theories of alcoholic dependence, . 
the possibility that biogenic amines may play a role in the expres-
sion of withdrawal symptoms has been discussed (1,2). It has been 
suggested that acetaldehyde (AcD) formed from the metabolism of · 
etqanol or catecholamine (CA)- derived aldehydes elevated due to AcD, 
·. condense with CAs in nerve terminals and chromaffin cells to produce 
active 1,2,3,4, - tetrahydroisoquinoline (TIQ) alkaloid agents. 
To date there are no .reports on the biosynthesis of TIQs in an-
imal tissues during ethanol ingestion. The purpose of this research 
is to explore, with electron capture gas chromatography (EC/GC), the 
possibility of TIQ alkaloid formation in rat brain and in adrenal 
glands during acute or chronic intoxication with ethanol. The quan-
titative changes in CA levels during alcohol metabolism are also 
evaluated, using the highly sensitive chromatographic method. 
B. BACKGROUND 
There appears to be little doubt that alcohol markedly affects 
the function of the central nervous system (CNS), as reflected by 
euphoria, loss of motor control, unconsciousness and severe 
physiological dependence. Unfortunately, there is no one satisfac-
tory explanation of the biochemical mechanisms by which ethanol 
induces its neurological effects. However, several lines of evidence 
connecting the biogenic amines with the depressive and addictive 
.. \ 
actions o.f this drug· have been put forth and are discussed in the 
following three sections. 
I. EFFECT OF ETHANOL AND ACETALDEHYDE ON NEUROAMINE METABOLISM 
Ample evidence indicates that the biogenic amines (serotonin or 
5-hydroxy-tryptamine (5-l:IT), norepinephrine (NE) and dopamine (DA) 
are localized in specific neurons and nerve terminals in the CNS 
(3,4) and that they function as chemical transmitters (5). Inter-
action of these neuroregulatory compounds with the ethanol metabolite, 
·. AcD, might result in abnormal levels or types of amine metabolites 
which would underlie the behavioral ~berrations manifested in clin-
ical alcoholism (6). This relationship in fact has been the basis 
for the numerous studies seeking to elucidate biochemical changes 
involved in human alcoholism. 
Reports of the changes in the pattern of urinary CA metabolites 
after the ingestion of ethanol at various dose levels have appeared · 
frequently. Smith et al (7) were the first to show that ethanol 
altered the metabolism of infused NE in humans from the oxidative 
pathway (vanillyl mandelic acid or VMA formation) to the reductive 
pathway (3-methoxy-4-hydroxy phenylglycol or MHPG formation, Fig.1). 
Similar findings have been reported by Davis and co-workers (8) in 
that ethanol induced a shift from VMA to the glycol derivative after 
intravenous (i.v.) ethanol injection in humans. The alteration 
in urinary _5- HT metabolites after ingestion of ethanol has been 
reported to be similar to that in NE metabolism (9). 
The effect of ethanol on the peripheral metabolism of DA in 
-2-
OH OH 
HO CH30 COMT 
HO HO 
lMAO 
OH OH 
CH3o 
CH3 o 
E1 HO 
: VMA /s2 
OH 
CH 3 0 
HO 
MHPG 
Fig. 1 Major pathway of norepinephrine catabolism in humans 
El, aldehyde dehydrogenase ; E?, aldehyde reductase. 
Modified from A.A. Smith and S. Gltlow (7) 
-3-
'• 
humans has not been studied. The results obtained in the ethanol-
intoxicated rat (10) show a decreased level of acid metabolites of 
DA in urine, with no concomitant increase in the alcohol derivatives 
(3-methoxy-4-hydroxyphenyl ethanol and 3,4-dihydroxyphenyl ethanol). 
Apparently, however, the shift to a reductive pathway does not 
occur in the CNS. Tytell and Myers (11) compared the effect of 
acute and chronic ethanol administration on 14c-5-Hr metabolism in 
the rat brain. They did not observe large differences in CNS 
production of 5-hydroxy-tryptophol between the alcoholic groups 
and control. Instead, compared to control rats, they found a signif-
icant CNS conversion of 14c-5-Hr to 5-hydroxyindole acetic acid 
(5-HIAA) in both acute and chronic ethanol treated rats, with a 
higher 5-HIAA level in acute ethanol treated rats. A similar 
observation of increase in 5-HIAA level in mouse brain, both after 
acute and chronic administration of ethanol, was reported by 
Tabakoff (12). The conflicting results reported on this subject 
are suggested to be due to the functional differences of 5-Hr meta-
bolism in the periphery and CNS (11). NE and DA have not been 
studied centrally with regard to the effect of ethanol metabolism. 
Various explanations have been suggested for the effect of 
alcohol on peripheral CA metabolism: inhibition of monoamine 
oxidase·(MAO) (13); a depletion of nicotinamide adenine dinucleo-
tide (NAD, oxidized from, and NADH, reduced fonn) with a resultant 
increase of NADH/NAD ratio due to the oxidation of ethanol (8,12), 
and finally a competitive inhibition between AcD (derived from 
ethanol) and the intennediate biogenic aldehydes (MAO products) for 
I'··'· 
-4-
the K;ti'Vflt sitlit on· aldehyde dehyd1:0genase (8, 14). Recently, 
supporting evidence for the competitive inhibition hypothesis has 
been reported (15,16). It was shown that AcD in the presence of 
excess NAD still caused a decrease in the formation of 14c-5-HIAA 
with a simultaneous increase in the neutral fraction (presumably 
5-hydroxy-tryptophol) in rat brain homogenates (17). 
II. EFFECT OF ETHANOL AND ACETALDEHYDE ON NEUROAMINE STORAGE AND 
RELEASE PROCESSES. 
Ethanol has been reported to increase urinary epinephrine (E) 
and NE levels in the rat (18). Klingman et al (19) reported that 
an acute sublethal dose of alcohol in dogs produced a marked in-
.crease in urinary E and NE. After adrenalectomy, only E excretion 
was decreased. These workers found that ethanol lowers the adrenal 
content of E without a significant effect on NE content• The main 
emphases of the above experimental works have been concerned with 
the action of ethanol on the storage and release of E from the 
adrenal medulla and depletion of NE from sympathetic adrenergic 
nerves (19). 
In humans, ethanol consumption has been shown by several inves-
tigators to increase the release and excretion of CAs (20,21,22). 
Alcoholics who showed withdrawal symptoms in controlled intoxica-
tion studies continued to excrete larger amounts of urinary E and 
NE, whereas in those alcoholics not showing withdrawal symptoms 
the urinary CA concentrations returned to prealcohol baselines(21). 
This increase in urinary excretion of NE and E following cessation 
of ethanol intake in alcoholics during withdrawal appears to be 
-5-
'• 
a.ssaciated vdt.h a ~neralized activation of the sympathetic nervous 
system (22,23). 
Some investigators very early suggested that the release of 
neuroamines by ethanol.might well be due to its metabolites rather 
than, or in addition to, alcohol. Perman (24) found that i.v. 
injection of AcD in the cat produced a marked increase of E and NE 
levels in the suprarenal venous plasma. Therefore he suggested that 
AcD derived from ethanol may be the active agent responsible1 for the 
increased level of the urinary CAs. Using purified adrenal prepara-
tions, Akabane et al (25) were able to show that AcD intensifies 
the secretion of both E and NE from medulla. They indicated that 
CA release was closely correlated with an action of AcD on the 
membrane storage sites. Walsh and Truitt (26) reported that after 
i.v. administration of 3H-NE in cats and rabbits, AcD produced a 
much larger and more innnediate release of the neuroamines into the 
plasma from peripheral nerve terminals than did ethanol. 
CNS stores of biogenic amines also have been studied in regard 
to the effect of ethanol and in general the findings are controver-
sial. Gursey et al (27) and Gursey and Olsen (28) found that i.v. 
administration of ethanol produced a significant reduction in rabbit 
brain stem 5-IIT and NE. They felt that the effect of ethanol 
resembles that of reserpine in action, because they found that the 
reduction in central amine stores lasted several days. Other 
investigators have not found any effect of ethanol on the brain 
content of the amines (30,31,32,33). However, Corrodi et al (29) 
could demonstrate an alcohol-induced decrease in rat brain stem NE 
-6-
'• 
iu tha ahsenca of compensatmiey: GA synthesis, by administration of 
c1t~methyl-p-tyrosine, a tyrosine hydroxylase inhibitor. 
Duritz and Truitt (34) suggested that this discrepancy may be 
because AcD is responsible for this effect. Intraperitoneal (i.p.) 
administration of AcD or of ethanol plus disulf iram induced a 
decrease in rat and rabbit brain NE, which was not seen with acute 
ethanol alone. They concluded that differences in brain amine 
liability to AcD, as well as the required time for maximal blood 
AcD levels after ethanol ingestion in different species, were crit-
ical factors. 
III. FORMATION OF ALKALOID CONDENSATION PRODUCTS FROM NEUROAfIINES 
AND ALDEHYDES. 
During ethanol metabolism the level of AcD, chemically a very 
reactive substance, increases in body fluid and cells. Table l 
demonstrates various biochemical substances which can easily react 
with AcD. A non-enzymatic condensation reaction has been shown to 
occur readily at physiological conditions between the amino groups 
of B-aryl ethylamines and carbonyl compounds, including AcD, to 
form varieties of cyclic compounds, B-carbolines in case of 
indolamines (tryptamine and 5-HT) and TIQs in case of m-hydroxylat-
ed phenethylamines (NE, E, DA). 
a. CAs Simple TIQs (1-alkyl-TIQs) 
In 1970, Cohen and Collins (1) reported that TIQ biosynthesis 
takes place in the medulla of isolated cow adrenal glands fol-
lowing perfusion with dilute AcD in isotonic phosphate buffer 
(pH 7) at 37"C Later Cohen (44) confirmed TIQ formation in 
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TABLE 1 
Known chemical reactions between acetaldehyde and biological substrates - Modified from M.J.Walsq(35) 
Reactant 
A) Pyruvate 
O<- ketoglutarate 
B) Coenzyme A (Co A) 
C) Various amines 
1. Indolamines 
5-methoxy-tryptamine 
tryptamine and 5-HT 
2. Catecholamines (CA) 
epinephrine (E) 
norepinephrine (NE) 
dopamine (DA) 
D) Amino acid: DOPA 
Product 
Acetoin 
5-hydroxy-4-ketohexanoic acid 
Semi mercaptal formation; reported to 
decrease brain and liver levels of active 
Co A 
presumed Schiff base formation 
B-carbolines 
10-methoxy-harmalan 
1-methyl-harmaline 
Reference 
(36) 
(37) 
(38) 
(39) 
(40) 
(41) 
1,2,3,4-tetrahydroiso-quinolines (TIQs) 
l,2-dimethyl-4,6,7-trihydroxy-TIQ (gigantinol*)( 1) 
1-methyl 4,6,7, trihydroxy- TIQ ( 1) 
l-methyl-6,7-dihydroxy-TIQ (salsolinol) (42) 
1-methyl-3-carboxy-6,7-dihydroxy-TIQ (43) 
* This compound is hereafter referred to by its trivial name gigantinol, which is derived from the 
name ascribed to its 6,7-dimethoxylated isomer, the only isolated 4-hydroxy-TIQ, gigantine (from 
Carnegia Gigantea) (120), 
-8-
'~ 
~;-
,, 
the perfused adrenal gland at phy~iological (1-2 ug/ml) concentra-
14 
tions of C-Acll. The presumed reaction sequence of TIQ formation 
is presented in Fig.2. 
Formaldehyde (HCHO)-derived TIQ biosynthesis was promoted in the 
rat adrenal glands during 14c-methanol metabolism (45). They 
observed the presence of the radioactive TIQs by thin layer chro-
matography, while E and NE were not radioactive. Further evidence 
for TIQ synthesis in vivo was obtained by Cohen and Barrett (46), 
who reported that TIQs were detected by fluorescence microscopy in 
lyophylized slices of adrenal tissue taken from rats chronically 
intoxicated with non-radioactive methanol. 
Robbins (47) reported on the chemical reaction capability of 
several biogenic amines with AcD and suggested that such a reaction 
might occur in extracellular body fluid after ethanol ingestion. 
Yamanaka and coworkers (42) observed salsolinol formation in the 
-,, 
homogenates of rat brain, stem and liver incubated with 14c-DA and 
AcD. Based on these findings, Cohen and Collins (1) and Yamanaka 
et al (42) have suggested that physical dependency and 'withdrawal 
symptoms of alcoholics may be partly related to the formation of 
simple T!Qs in nerve tissue. 
b. CAs -----. Benzylisoquinolines 
Holtz and coworkers (48) originally described in vitro condensa-
tion of DA with its aldehyde, 3,4-dihydroxy phenylacetaldehyde, 
resulting in the formation of the 1-benzyl-TIQ, tetrahydropapav-
eroline (THP). Davis and Walsh (2) showed in vitro that AcD 
inhibits aldehyde dehydrogenase activity and leads to the accumula-
-9-
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OH 
R' CHO · 
R= H; norepinephrine (NE) , 
R=CH3;epinephrine (E) 
R=H; CH3 
HO 
HO + R' CHO 
Dopamine (DA) 
•"' 
OH 
4,6,7-trihydroxy-1,2,3,4-
Tetrahydroisoguinoline 
HO 
R' 
6,7-dihydroxy-1,2,3,4-
Tetrahydroisoguinoline 
R= CH3; salsolinol 
Fig. 2 Formation of tetrahydroisoquinoline (TIQ) alkaloids. 
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u 9n of 3,4-dihydroxy phenylacetaldehy~e. This latter metabolite 
eondenses with the second molecule of DA, and THP is formed ( Fig. 3). 
THP h.8s been reported to be an intermediate compound in the biosynthesis 
of morphine (81). This had led Davis and Walsh to suggest (2) that 
alcohol addiction may be associated with the formation of this TIQ 
alkaloid. They reasoned that the formation of THP in brain tissue with 
relatively low aldehyde dehydrogenase activity is more likely than in 
other tissues which have high aldehyde oxidizing capacity. 
It also has been stated that NE reacts with its biogenic glycol-
·. aldehyde to form the analogous dihydroxylated THP (35). Similarly, a 
condensation product of 5-HT and its aldehyde was indicated by thin 
layer chromatographic (TLC) analysiS, Thus, complex alkaloid formation 
appears to be a general reaction in vitro in the presence of MAO (35). 
Sandler and coworkers (49) recently provided support for the 
hypotheses of simple (1) and complex (2) TIQ formation by detecting 
salsolinol and THP in the urine of Parkinsonian males who had been 
treated with therapeutic amounts of L-DOPA. Ethanol administration 
increased the level of urinary salsolinol in these patients. 
c. Indolethylamines - B-carboline alkaloids 
Taborsky and Mcisaac (41) performed extensive experiments in an 
attempt to isolate pure B-carbolines from the reaction of a number of 
tryptamine derivatives with AcD. They were unsuccessful in isolating 
a single purified product from serotonin and AcD reaction. However, 
the impure products they obtained from this amine proved to be 
-11-
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HO 
HO 
3,4-dihydroxyphenyl-
acetic acid HO·~cooH .. 
HOJV .. 
HO 
HO 
Dopamine (DA) 3,4-dihydroxyphenyl-
aceta}.dehyde 
HO 
HO 
HO 
Fig. 3 
HO 
Tetrahydropapaveroline HO 
(THP) 
NH 
HO 
I 0 I H 
' I
I 
• 
NR 
Normorphine, R=H 
Morphine, R=CH3 
Schematic representation of hypothesis illustrating an alteration 
in the metabolic disposition of DA produced by Ethanol (~) 
with the postulated resultant formation ~£ complex alkaloid 
derivatives. 
From V.E. Davis and M.J. Walsh (10). 
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potent MAO inhibitors and 5-HT antagonists and promoted aldosterone 
secretion. These are properties characteristic of B-carbolines. 
Later Mcisaac (40) reported the isolation of small amounts of 1-methyl-
6-methoxy-tetrahydro-B-carboline in the urine of rats treated with. 
ethanol, 5-methoxy-tryptamine, iproniazid (MAO inhibitor) and 
disulfiram (aldehyde dehydrogenase inhibitor). This finding points 
out the possibility of a reaction such as the one depicted in Fig.4 
to occur during alcohol ingestion in the pineal gland, a good source 
of 5-methoxytryptamine. Also very recently, Dajani and Saheb (50) 
isolated and identified l-methyl-6-hydroxy-B-carboline from the 
urine of rats that were injected with ethanol and 5-hydroxy-tryptophan 
plus inhibitors of MAO and aldehyde dehydrogenase. 
IV. CONDITIONS MODIFYING AMINE-ALDEHYDE CO~"'DENSATIO~~S 
The capacity of a .reaction occurring between AcD and almost every 
amine has been demonstrated. Several manipulations could promote 
formation of TIQ alkaloids. Increasing amine or aldehyde levels are 
the two major factors. Amine levels may be increased by inhibiting 
MAO oxidation, as was done with indolamines (vide suora), or pos-
sibly by inhibition of catechol-0-methyltransferase (COHT) methyl-
ation. Inhibiting AcD metabolism is a way of enhancing this reactant's 
concentration. Therefore, by increasing the AcD levels as well as by 
elevating CA levels, theoretically the formation of TIQ alkaloids 
would be promoted. Since CA derived TIQs are good COMT substrates(51, 
52), inhibition of 0-methylation may favor the detection of catechol 
TIQs. In the case of THP formation, it presumably can be promoted by 
any drug that competitively inhibits aldehyde dehydrogenase in tissue. 
;r, \ 
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Fig. 4 Proposed pathway for the formation of B-carboline alkaloids 
from indolamines,modified from W.M. Mcisaac (40) 
-14-
•. 
' 
'• 
V. RELEVANT PHYSIOLOGICAL AND PHARMACOLOGICAL STUDIES ON TETRA-
HYDROISOQUINOLINES . , 
· Early pharmacological research on simple TIQs has been discussed 
(53,62). More recently it has been noted that simple TIQs in vitro 
are accumulated by rat iris (54). This accumulation could be 
blocked by desmethylimipramine (an inhibitor of CA uptake). Sim-
llarly, ~IQ uptake by central catecholaminergic nerve terminals and 
inhibition of CA uptake have been reported. Cohen et al (55) 
observed that accumulated radioactive CAs in rat brain homogenate 
were released by salsolinol incubation. Simple TIQs derived from 
E and NE, biosynthesized in AcD-perfused cells, could be released 
by sympathetic stimulation (56). These findings indicate that TIQ 
alkaloids share the same transport .. and/or storage sit~~ in the 
nervous system and adrenal as the CAs. Therefore, Cohen (57) has 
suggested that TIQs might be capable of acting as 11false" adrenergic 
transmitters. TIQs of the salsolinol type -have been shown to have 
both central and peripheral pharmacological effects (58,59). These 
alkaloids may have either CNS depressant or stimulant and convulsant 
properties (58,59), lypolytic activity (60,61), and various effects 
on smooth muscles (59). 
As discussed by Collins (63), very few simple alkaloids possess-
ing a hydroxy group at the 4-position on the TIQ ring are known to 
occur naturally, and no physiological studies have been done on 
synthesized compounds analagous to those formed from the condensa-
tions of E and NE with AcD. Recently, however, some evidence has 
I 
been obtained suggesting that 4-hydroxy-TIQs may be key intermediates 
in the bio.syntheses of several classes of complex alkaloids (64). 
-15- ' ' 
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On tbe other hand', THP has been more fully investigated. Some 
of its pharmacological effects on respiration, blood pressure and 
smooth muscle were described in 1910 (65). This alkaloid is 
sympathomimetic (65), evoking positive inotropic and chronotropic 
responses and decreases in blood pressure with accompanying 
increases in peripheral blood flow (10). In addition, relaxation 
of isolated smooth muscle preparations such as uterus, intestine 
and trachea is produced by THP (66). Furthermore, mobilization of 
lipid both in vivo (67) and in vitro (68) is enhanced by this 
alkaloid. All of the pharmacological effects reported for THP can 
be prevented by B-adrenergic blockl.ng agents (65,66,67,:68). 
VI. THE POSSIBLE INVOLVEMENT OF NEUROAMINE-DERIVED ALKALOIDS IN 
ALCOHOLISM. 
Ethanol directly or indirectly affects neuroamine metabolism, 
but the significance of these effects in relation to physiological 
and behavioral aberrations in alcoholism has not been defined. 
However, there are several theories proposed to account for the 
above-mentioned abnormalities found in human alcoholism. Several 
groups of workers believe that the condensation products of biogenic 
amines and aldehydes may be important metabolites in the utilization 
of ethanol. The first general hypothesis related to this topic 
came from Mcisaac (40). In 1961, he put forth a general biochemical 
concept of mental disease. He suggested that normally circulating 
AcD in the body may condense with 5-methoxy-tryptamine (O-methylated 
serotonin) to form 10-methoxy-harmalan, a potent serotonin antagonist 
and MAO inhibitor. 
-16- "'' \ 
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Cohen and Collins hypothesized (described in part I) that, due 
to the ease of biosynthesis of TIQ alkaloids in adrenal tissue dur-
ing AcD perfusion, the possibility of TIQ formation at adrenergic 
fibers of the sympathetic nervous system and brain is likely (1). 
If so, the TIQ alkaloids, either actively secreted or leaked from 
nerve termini, could contribute to the behavioral changes observed 
in alcoholic people. They also suggested that the· signs of physical 
dependence such as tremulousness, hallucinosis and seizures which 
occur when concentrations of alcohol in blood (and brain) are falling 
may be due to persisten physiological actions of TIQ alkaloids. 
Amit and Stern (69) suggested that NE-derived TIQs were syn-
thesized in the nervous systems of their experimental rats. The 
animals were made alcohol dependent by electrical stimulation of 
the lateral hypothalamus. Free cluice of alcohol consumption by 
increasing the concentration of alcohol daily permitted the inges-
.tion of significant volumes of alcohol. A reasonable model was 
proposed for the role of TIQ thought to be formed in the synaptic 
gaps by interaction of AcD with NE. Increased precursor NE levels 
were suggested to occur due to the electrical stimulation. NE-
derived alkaloids would be taken up by the same presynaptic cells 
from which the NE was initially released. As a result, the pre-
synaptic cells involved would adapt to this new TIQ substance and 
it gradually would become the neural transmitter for that part of 
the nervous system. Once adaptation to alkaloid is complete, the 
neural system presumably cannot function well without it. Thus, 
the system would require regular intake of alcohol in order to 
-17-
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fuaction. Earlier investi~: (7Q.,.71) had brought out the same 
sort of hypothesis suggesting that alcoholics may have an impaired 
sympathetic nervous system which may be normalized by ethanol. 
Davis and Walsh (2) have put forth the possibility of THP forma-
tion in the CNS and its involvement in the disease of alcoholism, 
although this theory, like the simple TIQ hypothesis, is controver-
sial (72,73). These workers demonstrated the augmentation of THP 
biosynthesis when ethanol or AcD and DA were incubated with brain 
or liver homogenate. Furthennore, it is known that in plant~ THP 
is a natural biosynthetic intermediate in the synthesis of morphine 
alkaloids (81). 
It should be added that indirect support of addictive TIQ forma-
tion was reported by Sprince and coworkers (74). These investigators 
found that, compared with controls, rats on a diet supplewented 
with DOPA tend to prefer an ethanol solution to water. 
VII. ANIMAL MODELS OF ALCOHOLISM 
Induction of alcohol addiction in laboratory ani~2ls, to provide 
a model to study the neurochemical aspects of alcoholism, is partic-
ularly important ( 137, 138) 
Numerous workers have attempted to produce signs of physical 
dependence and subsequent withdrawal syndromes with ethanol in a 
variety of animals. Very little success has been achieved in 
inducing ethanol withdrawal syndromes in animals by the voluntary 
drinking of aqueous ethanol solutions. In rodents, usually most 
ethanol is consumed during the night, leaving the daytime for 
recovery. But Freund (75) found that 1 iquid diet in which 35~~ of 
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cad:O'ries came from ethanol produce<l: physical dependence in mice 
within four days. Ellis and Pick (76) developed an alcohol 
intubation method that produced human-like withdrawal symptoms in 
monkeys and dogs that could be suppressed by ethanol administration. 
Recently Majchrowicz (77) has reported alcohol dependence in rats 
after eight days ~f gastric intubation. Pieper et al (78) recently 
found that young chimpanzees voluntarily consuming ethanol dem-
onstrated withdrawal symptoms similar to those observed in humans. 
Goldstein's method (79) of inducing physical dependence involves 
closed chambers in which mice breathe ethanol vapor. 
VIII. GAS CHROMATOGRAPHIC DETERMINATION OF CATECHOULHNES 
In gas chromatographic (GC) analysis, it is often necessary to 
prepare derivatives of substances to be analyzed. The aim of deriv-
ative formation is to increase the volatility of the conpound and to 
reduce its polarity. In addition, derivative formation r.3y give 
information by causing changes in retention time (80,99). 
GC analysis, potentially as sensitive as fluorometry, may be the 
most specific method available for the estimation of biological 
amines. With electron capture (EC) detectors, as little as lo-12 
grams (picogram) or less of some compounds can be detected, but this 
requires certain halogenated derivatives which are good electrol 
acceptors. 
GC analysis of CAs have been done by a number of groups using 
trimethyl-sylyl derivatives. Horning et al (82) published a 
method of O, N-trimethylsilyl formation of CAs with trimethylsilyl 
imidazole and bis-trimethylsilyl acetamide. Fluoroacyl deriva-
-19-
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tives of CAs for EC detection recently have been employed by the 
workers in the field. Recently Arnold and Ford (83) prepared 
different fluorinated derivatives of CAs using trifluoroacetic 
(TFA) anhydride, pentafluoropropionic (PFP) anhydride and 
heptafluorobutyric (HFB) anhydride in acetonitrile. HFB deriva-
tives showed the highest sensitivity of the three. They measured 
CA levels in rat brain tissue.~.artin and A..~sell (84) reported EC/ 
GC estimation of DA, NE, and 5-iIT in rat brain using TFA-anhydride 
in acetonitrile. Koslow and coworkers (85), using mass frag-
mentography, a technique in which the mass spectrometer is used as a 
single or multiple ion chromatographic detector, assayed NE and DA 
in 0.1 mg tissue in the picomole range. They used PFP-anhydride 
in ethyl acetate as a derivatizing agent. 
IX. GAS CHROMATOGRAPHIC DETE&.'1Il1ATION OF TETRAHYDROISOQUeOLDiE 
ALKALOIDS. 
Only a limited number of TIQ studies have been er:-ployed using 
GC methods. Agurell (86) has carried out GC studies on TIQ plant 
alkaloids with a flame ionization (FI) detector. Cashaw et al 
(87) developed a flame ionization GC method for determination of 
TIQs including salsolinol and THP in urine. They have used 
trimethylsilyl derivatives which are not applicable for EC d,~tec-
tors. More over, this work was not applied to the study of endoge-
nous amines in tissue. Sandler et al (49) performed EC-GC analyses 
of the urine from Parkinsonian patients for the detection of 
salsolinol and THP, employing PFP derivatives. This work was not 
concerned with the simultaneous separation and measurement of CAs 
and TIQs. 
-20-
--
A. MATERIALS 
I. CHEMICALS 
PART TWO 
EXPERIMENTAL SECTION 
Derivatizing agents (HFB anhydride, PFP anhydride, sylilation 
grade acetonitrile) were purchase:! from Pierce Chem.ical Company. All 
of these reagents were kept refrigerated. Ethyl acetate (Pierce 
Chemical Company) was distilled before use. L-(-)-E and L-(-)-NE 
were obtained from Regis Chemical Company. The hydrochloride salts 
of metanephrine and normetanephrine were purchased from Winthrop 
Laboratories. Salsolinol hydrobromide was obtained from Aldrich 
Chemical Company. The hydrochloride salts of 4-hydroxy-TIQs were 
synthesized in our laboratory (88). The structures of those used in 
our experiments are shmm in Fig. 5. THP was obtained as a gift 
from Wel:ome Laboratories, England. Aluminum oxide (A1203) (Woelm, 
neutral activity grade) was activated by the procedure of Anton and 
Sayre (89) and was stored in a desiccator over drierite. Perchloric 
acid and sodium metabisulfite (J.T. Baker Chemical) were c.p. grade. 
Bitartrate salts of radioactive CAs (14c-DA, 14c-E) were obtained 
from Amersham/Searle. All solvents for scintillation counting were 
purchased from Beckman Chemicals. 
II. ANilIALS 
Male Sprague-Dawley rats (Holtzman) weighing 350 ± 20 grams were 
used in all experiments with the exception of the pyrogallol/methanol 
experiment (vide infra). 
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OH 
CH
3 
1-methyl 4,6,7-
trihydroxy-TIQ 
( ff 1 ) 
OH 
HO 
HO 
OH 
HO 
CH3 
1,2 dimethyl-4,6,7-
trihydroxy-TIQ (gigantinol) 
HO 
HO 
CH3 1-methyl-6,7-dihydroxy-
TIQ (salsolinol) HO 
(if 3) 
HO 
( ff 2 ) 
OH 
4, 6 ,7~ trihydroxy-TIQ 2-methyl-4,6,7-trihydroxy-
TIQ (1-norgigantinol) 
( ff 4 ) 
OH 
6-methoxy-4,7-dihydroxy-
TIQ 
( ff 7 ) 
(ifa 9) 
HO ( ff 5 ) 
6,7-dihydroxy-TIQ 
(if 6) 
CH 0 
3 
HO 
CH 
1-methyl-6-methoxy 3 
7-hydroxy-TIQ 
( ff 8 ) 
Tetrahydropapaveroline 
(THP) 
Fig_. 5 1,2,3,4-tetrahydrois<;>quinolines (TIQs) used in these studies 
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III. GAS CHROMATOGRAPHY 
The analyses were performed on a Varian Model 2100 GC instrument 
equipped with electron capture (EC) and flame ionization detectors 
and injection port extenders. The 63Ni-EC detector was operated 
on a direct current mode. Carrier gas was nitrogen (Nz) (zero 
grade, Liquid Carbonic). U-shaped glass columns (1/8 inch i.d. X 
6 feet) were used. All column packings were prepared in our 
laboratory using a solvent evaporation technique with a rotary 
flash evaporator (90). The basic solid support was 80/100 mesh 
Gas Chrom Q (Applied Science Laboratories) coated with various 
liquid phases: SE-30, Silar, SE-54, OV-17, GE XF-1105 (Applied 
Science Laboratories), SE-52 (Varian Aerograph), and Dexil 300 
(Regis Chemical Company). Carbosieve 60/80 mesh (Supelco, Inc.) or 
Porapak QS 80/100 mesh (Water Associates, Inc.) were employed for 
ethanol and AcH determinations. Columns were conditioned at their 
maximum temperature for 24-36 hours with a Nz flow rate of 20 ml/ 
.min. 
B. METHODS 
I. PREPARATION OF FLUOROACYL DERIVATIVES 
To 1 mg of the catechol compound in 5 nl screw capped vials, 
0.1 ml acetonitrile and 0.2 ml HFB anhy]ride or PFP anhydride were 
added. To each sample of tissue extract a total of 0.2 ml aceto-
nitrile plus 0.4 ml HFB anhydride was added. Each vial was covered 
with aluminum foil, capped, and left at room temperature. After 
30-60 minutes the solution was dried under a N2 stream. The vial 
was then tightly capped and stored at-20~C until used ~for GC 
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analysis. Dried derivatives obtained in this way were redissolved 
in distilled ethyl acetate to the appropriate concentration prior 
to analysis. TIQ #1 and #2 (Fig.5), which were not available as 
crystalline compounds, were prepared by the method of Cohen and 
Collins (1) by condensation of AcD with NE and E respectively, and 
were then derivatized following lyophilization (vide infra). THP 
fluoroacyl derivatives were prepared from the hydrochloride salt, 
which was made by dissolving 5 mg THP base in 2 ml 0.05 N HCli in 
methanol ( 1 : 99 v/v) and evaporating the solution with a N2 
stream. 0-methyl metabolites of CAs and TIQs were derivatized in 
the same manner. 
II. PREPARATION OF CALIBRATION CURVES 
In order to determine quantitative measurements and linearity 
of detector response to catechol compounds, calibration curves were 
constructed by plotting the peak height versus picogram (pg) 
·substrate. A stock solution (1 mg/ml in ethyl acetate) of each 
derivative was prepared. In the case of TIQ ffl and TIQ il2, the 
concentration of each calibration solution was based on the weight 
of parent amines (E and NE) before reaction. In the situation where 
the peak areas were measurable, the calibration curves were also 
prepared by plotting the peak area (planimetric method) versus the 
concentration, thus permitting comparison of data by two measurements. 
Calibration curves were determined for each experiment, in order to 
guard against changes in EC detector response to a particular amine. 
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III. EXTRACTION OF CATECHOL COMPOUNDS FROM TISSUE 
The entire extraction procedure is sunnnarized in Fig. 6. Each 
sample of tissue (either whole brain, combined brain parts or pair 
of adrenal glands) from a single rat was weighed, transferred to a 
5-ml conical homogenizing tube (Kontes Glass Company) containing a 
2 ml mixture of 1 N perchloric acid and 0.05 M sodium metabisulfite. 
The sample was homogenized for five minutes while the tube was 
immersed in an ice-cold bath. All centrifugations were done in the 
cold room (4°C) in a clinical centrifuge. The homogenate was 
centrifuged at 2,000 rpm for 15 min. and the resulting supernatant 
was removed with a Pasteur pipette and was transferred to a 15-ml 
screw-capped vial. The precipitate was rinsed with another 2 ml of 
the homogenizing media and was centrifuged as previously described. 
Both supernatants were pooled and saved, and the precipitate was 
discarded. 14c-DA (purified with Al2o3 prior to use) was added to 
the supernatant obtained from brain homogenate in order to determine 
the percent recovery. 10% of the total brain homogenate was 
examined by scintillation spectroscopy, while the remaining 90 
percent of the supernatant was used for Al2o3 extraction of catechol 
compounds. 14 Purified C-E was added to the adrenal homogenate for 
the same purpose and the same steps were followed. 
IV. Al203 CATECHOL EXTRACTION PROCEDURE 
The pH of the supernatant (above) was brought to between 6-7 by 
.the addition of 1 N NaOH. Activated Al203 (100 mg) was added and pH 
was adjusted to 8-8.2 by careful addition of 0.2 N NaOH. The mixture 
was shaken with a mechanical shaker for ten minutes. T~e Al2o3 was 
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G.C. monitoring of ethanol 
and AcD blood levels 
1 
Experimental or control 
rat 
• Brain, brain parts or adrenal 
tissue (1 N HC104 + 0.005% 
Na2s205) 
1 
homogenize 
centrifuge 
Discard precipitate Supernatant 
..------------------ij add l4c-DA or 14c-E 
l 1 
10% of aliquot for 90% of Aliquot 
scintillation counting J 
Supernatant for assay 
for 0-methyl-CAs 
Al203, pH 8.0-8.5 
shake 10 min 
i 
Al 203 and bound material; 
!wash three tiwes with distilled water 
0.1 N HCl 
.--~~~~~~~~~~~~~~---ijshake 10 min 
J 
Supernatant ! lyophyl iza tion 
Fluoroacylation in ! acetonitrile 
!evaporation with N2 
Residue 
r-~~~~~~~~~~~~~~~Jdissolve in Ethyl acetate 
! 1 
Take 50% of aliquot for 
scintillation counting 
I EC/GC analysis I 
Fig. 6 General Procedure for the Isolation of Tissue Catechols with 
Activated Aluminum Oxide (Al203) and their derivatization for EC/GC 
analysis. 
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allowed to settle and supernatant was transferred to another test tube 
with a Pasteur pipette and stored in the freezer for subsequent anal-
ysis of phenolic CA metabolites. The Al203 portion was washed with 
three 5-ml portions of distilled water. The catechol compounds were 
then eluted from A1 2o3 by shaking for ten minutes with 2 ml 0.1 N HCl. 
The Alz03 was discarded and the acid supernatant was lyophylized. The 
dried residue was stored at-zooc for later derivatization. 
In some instances, a prior purification step was done on brain 
homogenate. Fatty substances were removed (91) by ten volumes of a 
mixture of organic solvents (ether-benzene 5:2) added to the super-
natant portion of the homogenate. The aqueous layer was then processed 
through the Alz03 purification procedure. 
V. ION EXCHANGE COLUMN CHRO~·!l1 .. TOGRAPHY OF PHENOLIC Cl\ ~fETABOLITES 
Dowex AG50-WX (50 gm) was washed four times with distilled 
water and acidified under the flow of eight liters of 2N HCl passing 
dropwise through a column. The acidified Dowex was brought to neutral 
pH in the same column with distilled water. 
The Dowex, stored under distilled water, was poured into a 4 mm 
i.d. narrow-tip column until a packing height of ca. lcm was obtained. 
The supernatant from the Al203 extraction (the solution containing 
phenolic CA metabolites) was passed through the column after adjusting 
the pH to 3;5 with phosphate buffer (0.1 M KHzP04 + 0.1 M NaOH). 
The column was washed with four 2 - ml portions of distilled 
water. The adsorbed materials were. then eluted with 2 ml 
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o:f. a: 1: 1 mixture of 6N. HCl.: absolute ethanol (v/v) (121), and the 
eluant was lyophylized and stored in the freezer for future deriv-
atization. 
VI. QUANTITATIVE AND QUALITATIVE MEASUREMENT OF PFP AND HFB 
DERIVATIZED CAs AND TIQs 
Since the linearity of the EC detector is limited, the concentra-
tion of the HFB or PFP derivatives in ethyl acetate was adjusted to 
be in the range of pg/ml. However, a problem arose in the quantita-
tion of the suspected TIQ alkaloids in the tissue of the alcohol 
treated animals, since they were present in such minute concentra-
tions. This necessitated the injection of a concentrated solution 
of the derivatives, which precluded obtaining precise quantitative 
results. In previous work (53) it was observed that HFB derivatives 
were not stable at room temperature in ethyl acetate long enough to 
complete both quantitative and qualitative measurewents on all sam-
ples, especially when these -investigations require changing GC 
columns (which then take 12-16 hr to become equilibrated!. 
Therefore, when the catechol compound from each rat's brain parts 
or adrenals were extracted and derivatized, the resulting soluti8n 
was divided into two portions (10% and 90% v/v). Both were dried 
under a tream of Nz. The larger portion, to be used for qualitative 
analysis, was stored at-20°c. The smaller portion was 
dissolved in 5 ml ethyl acetate. One ul of this diluted solution 
was analyzed quantitatively for CAs by EC/GC (GE XF-1105) 
at 4 to 8 x lo-lO AFS electrometer settings. Peak heights were 
measured and the concentrations of CAs or their metabolites (un-
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corrected for recovery) per g tissue were calculated using the 
calibration curves. In the third pyrogallol/acute ethanol exper-
iment (Results, vide infra), adrenal CAs were determined per g 
protein as well as per g tissue. Adrenal protein was measured 
spectrophotometrically by the method of Lowry (122). 
The larger portion, used for qualitative analysis of potential 
TIQs at 1 to 4 x 10-lO AFS and for radioactive recovery, was 
dissolved in 1 ml distilled ethylacetate. Approximately 500 ul 
of this solutin was utilized to determine overall recovery by 
scintillation spectroscopy (representative calculation in Fig.7), 
and 1 ul portions of the remaining sample were injected on the GC 
column (3% OV-17). 
VII. QUANTITATIVE ANALYSIS OF ACETALDEHYDE AND ETE.•\XOL 2:.X BLOOD 
The estimation of AcD and ethanol levels in blood during 
chronic and acute alcohol intoxication was done by flane ionization 
GC, modifying the method of Coldwell et al (92) . Tail blood was 
sampled four times during acute intoxication (timing is sumrr~rized 
in Fig. 11) and once at the end of the chronic intubation ezper-
iment (two hours before sacrifice). For each sample, 20 ul blood 
was transferred by a heparinized micropipette onto a sodium 
fluoride impregnated paper disk in a 30-ml serum bottle ::~:.idi uas 
quickly stoppered and kept in ice. Before injectint the sample into 
the bottles were shaken at 35° C in a thermostatic metabolis shaker 
for 15 minutes to equilibrate the released gases. Aliquots of 1-2 ml 
head space gas from the serum bottle were injected on the GC column 
by means of a gas-tight syringe. 
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a. Preparation of Calibration Curves 
The calibration curves were prepared by dilution of aliquots of 
stock solutions of ethanol and of AcD to known concentrations with 
rat blood. The final concentrations in the standard solutions 
ranged from 0-3.0 mg/ml for ethanol and 0-80 ug/ml for AcD. The 
GC parameters were: 
Barber Coleman Model 53ZO GC: 
Column: Aluminum, 6 foot x ~ inch o.d. packed with Porapak QS 
(80/100 mesh, Water Assoc.), conditioned for Z4 hr at 180° C. 
Temps: Column= 145° C, Detector = 200° C 
Flow Rates: N2, 100 ml/min; Hz, 30 ml/min; Air, 300 ml/min; and 
Varian model 2100:GC: 
Column: Glass, 3 foot x 1/8 inch i.d. packed with Carbosieve-B 
·(60/80 mesh, Supelco Co.) conditioned for Z4 hr at 250° C. 
Temps: Column = 175° C Injector = Z30° C Detector = 250° C 
Flow Rates: N2 , 70 ml/min; Hz, 30 ml/min; Air, 300 ml/nin 
VIII. ACUTE ETHAi.'{OL !-'fETABOLISH STUDIES 
Acute intoxication experiments lasted eight hours eac~, fros 
1000 hrs to 1800 hrs. In order to control for circadian rhyth::i 
factors, this timing schedule was observed for all short-tee~ 
experiments. Since it is known that the levels of CA.s in rat brain 
fluctuate diurnally (93), any differences in CAs between experimen-
tal and control animals can be assumed to be due to the effect of 
alcohol. 
Drugs and alcohol solutions were prepared in 0.9% (isotonic) 
saline solution and administered according to the following sched-
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ules. After decapitation, combined brain parts, consisting of brain 
stem, caudate nucleus and midbrain, hypothalamus included, (or whole 
brain, in the case of the acute ethanol and methanol experiments)and 
rapidly frozen in liquid N2 or in dry ice. Organs from each animal were 
kept in small plastic bags (Whirl-Pak, Nasco) separately at-20°C until 
homogenization. The above procedures were performed in the cold in 
less than three minutes. 
(a) Ethanol 
Each rat received 3 g/kg of 25% (v/v) ethanol in isotonic saline i.p. at 
1100, 1350 and 1600 hr, while each control rats each received equivalent 
volumes of isotonic saline at these times. Two hr after the last 
injection, the animals were sacrificed and the organs were removed and 
frozen. 
(b) Pvrogallol/Ethanol 
In three different studies (December 12, 1972, December 30, 1972, and 
June 23, 1973), a total of 33 rats were each treated i. p. with 250 mg/kg 
pyrogallol in isotonic saline at 1000 hr. The 18 experimental ani1:1als 
were given three i.p. injections (3 g/kg each) of 25% ethanol solution 
(see VIII, a) 60, 210, and 360 min after pyrogallol treatment. Each of 
the 15 remaining rats received 6 ml of isotonic saline i.p., in place 
of ethanol. 
(c) DOPA/Pyrogallol/Ethanol 
In this study, experimental rats were treated as in experiment (b), but 
with two additional i.p. injections of 100 mg/kg 1-DOPA suspended 
in isotonic saline (4% w/v). The DOPA injections were given 
30 and 150 min after pyrogallol; control received equivalent 
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vo'lumes of isotonic saline at these times. 
(d) Pargyline/Pyrogallol/Ethanol 
Rats were injected i.p. once on each of two consecutive days with 100 
mg/kg pargyline in water (4% w/v). On the second day, one hr after 
pargyline at 0900 hr, all rats were treated as in experiment (b). 
(e) Reserpine/Pyrogallol/Ethanol 
Two groups of rats were injected i.p. with either 2 .5 !Ilg/kg reserpine 
(Serpasil, CIBA, 2-cc ampoules of 2.5 mg/cc) or vehicle of Serpas11. 
On the following day, all were treated with pyrogallol followed by 
ethanol or saline as in experiment (b) 
(£) Pyrogallol/Methanol 
The method used with nine animals (550 ~ 30 g) was the same as in 
Experinent (b), except that the methanol solution in experiment (g) 
replaced the ethanol solution 
(g) Me thano 1 
Rats were given i.p. 3g/kg methanol in isotonic saline (30/, v/v) at 
1200 hrs, followed by repeat injections at 1430 hr and 1700 hr. 
Two hr after the last injection, they were sacrificed. Controls were 
treated with 3 ml isotonic saline at the same times. 
IX. fHRONIC METABOLISM - "ALCOHOLIC" RAT STUDIES 
In two chronic intoxication experiments, rats were treated by two 
different routes (vide infra) with 25% ethanol (v/v) in water 
for 15 days. Depending on the state of intoxication of the animals, 
dai~y amounts ranged from 8-12 g/kg usually in 3 doses/day. 
They were housed in individual cages and all had free access to 
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water and, in the case o:fi th&- chironic i.p. experiment, lab chow·. 
Ethanol was isocalorically substituted by 21% (w/v) dextrose solu-
tion in the control-animals. During the e:Xperiments, food intake 
and body weight were recorded. 
Two different chronic intoxication studies were performed: 
a. Gastric Intubation 
In this method, ethanol or dextrose solution was administered by 
gavage with a four-inch urethral catheter attached to a 10-ml 
syringe. The experiment was started with two intubations/day of 
ethanol or isocaloric dextrose solution and raised on the 3rd day 
to 3 intubations (3-4 g/kg) at 0100, 0900 and 1700 hrs, according 
to Majchrowicz's procedure (77). The average amount of food and 
water consumed by the ethanol-treated rats was given to the controls 
the next day (pair-feeding). On the last (15th) day of this study, 
tail blood samples were collected at ca 1500 hr, to measure the AcD 
and ethanol levels 2 hr pre-sacrifice. 
b. i.p. Injection 
The conditions of this experiment were the same as above except for 
the route of administration and the absence of pair-feeJing. In this 
method, ethanol or dextrose solution was administered via i.p. 
injection. Along with the ethanol group, another group of rats was 
injected with the 3g{kg methanol in ~vater (25~~ v/v). Food and 
water were offered ad lib. Beginning on the fourth day of the treat-
ments, the animals in both experimental groups began to die. By the 
xisth day, insufficient numbers of ethanol and methanol injected rats 
were still alive, and therefore the experiment was discontinued. 
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A. DERIVATIZATION OF CAs A.~ TIQs 
PART THREE 
RESULTS 
I. HFB-DERIVATIVES OF CAs AJ-..TJ) SIMPLE TIQs 
In previous studies (53), a successful method for the EC/GC 
analysis of TIQ alkaloids concurrent with their parent compounds, 
CAs, was developed. Among different methods of derivation, the most 
suitable results were obtained by 30-60 min reactions of the amines 
at room temperature with HFB-anhydride in acetonitrile. A single 
derivative with a distinct retention time was obtained for each CA 
and TIQ, using 3-5% OV-17 or SE-30 columns. However, E and NE could 
not be separated on these columns; others have reported this dif-
ficulty with TFA derivatives of E and NE on similar column packings 
(94). Also, .some difficulties with the detection and separation of 
CA metabolites (0-methylated CAs ) existed when these liquid phases 
were used. Therefore, to improve the method, other liquid phases 
such as SE-52, SE-54, Dexil, Silar and GE XF-1105 were checked at 
different chromatographic conditions. 
With a 5% GE XF-1105 column, excellent separation of nearly all 
the HFB-derivative.s of CAs and their derived TIQs and of phenolic CA 
metabolites was obtained. Fig.Sa illustrates the retention times 
and relative responses to the EC detector of the HFB-derivatives of 
(SO pg each) DA, NE, E, salsolinol and 4,6,7-trihydroxy-TIQ, as well 
as the 1-methyl-TIQ reaction products of E and NE with AcH. Of 
special note is the separation of E, NE and DA (HFB derivatives), 
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which is. of significance. in adrenal. g) . .a.nd analyses. HFB-DA and HFB-
salsolinol were not separated on GE XF-1105. Therefore a 3% OV-17 
column, which readily separates these two derivatives, was used in 
future analyses of brain extracts. 
The minimum detectable quantity (MDQ), i.e., the amount of 
sample which gives a detector response equal to twice the noise level, 
consistently was smal~er on 5% GE XF-1105 for most HFB-amines than 
on any other liquid phase. Unusua.lly sensitive were HFB-DA (NDQ= · 
0.5-1 pg) and HFB-salsolinol (MDQ=0.2-0.5 pg). 
Fig. 8b is a chromatogram obtained by separation of 50 pg each 
of several 0-methylated metabolites of CAs and TIQs on a 5% GE XF-
1105 column. 
II. PFP-DERIVATIVES OF CAs Ai~D SIMPLE TIQs 
Table 2 illustrates the retention times of the PF? derivatives 
of some catechol compounds on different columns such as SE-52, SE-54 
and GE XF-1105. The relative EC detector responses to the PFP-
derivatives are shown in Table 2. SE-30 and SE-54 were accep::able. 
phases for resolution of a mixture of CAs and several TIQ derivatives 
with appreciable sensitivity. Overall, although direct comparisons 
were not done, the HFB- derivatives appeared to show more than 40-601~ 
greater sensitivity to EC detection than the PFP derivatives, i.n 
agreement with Arnold and Ford (83). 
III. DERIVATIZATION OF THP 
Attempts to derivatize crystalline THP (free base) with HFB or 
PFP anhydride in ethyl acetate or acetonitrile were unsuccessful 
under the usual conditions. However, the hydrochloride salt of THP 
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Table 2 
Retention times and EC/GC responses of PFP-derivatives of CAs and TIQs on various stationary phases 
Stationary 1. GC 
Phase Conditions2 
3% SE-30 A 
5% SE-52 A 
5% SE-54 A 
3io OV-17 B 
5% GE XF-1105 c 
1. On 80/100 Gas Chrom Q. 
2. A: N2 Flow Rate= 30 ml/min; T = 160°c B: N2 Flow Rate~ 30 ml/min; ·T = 170°c C: N2 Flow Rate= 35 ml/min; T = 175°c 
DA 
3.30 
4.10 
4.10 
4.20 
7.40 
Retention Time {min2 l 
NE E Salsolino 
4.50 5.00 
- -
2.45 - - 6.00 
2.50 2.50 6.45 
2.30 2.30 6.45 
9.10 5.15 7.40 
3. ng amines which give 50% deflection at 4 x 10 -lo AFS. 
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Sensitivity) 
DA NE E Salsolinol 
0.12 0.28 0.25 
0.20 0.25 - - 0.18 
0.20 0.30 0.25 0.10 
0.15 0.20 0.18 0.15 
0.10 0.25 0.20 0.10 
was readily derivatized with these reagents; the derivatives were 
examined on different columns (Table 3). Analogous to the other 
catechol compounds, the HFB-derivative of THP demonstrated a greater 
EC sensitivity than the PFP derivative. Relative sensitivity and 
retention times of the two fluoroacyl THP derivatives are shown in 
Table 3. It was observed thatPFP-THP sensitivity was strikingly low 
on all columns, with an MDQ of 200-250 pg (or sens~tivity, as defined 
in table 3, of 2-5 ng). 
B. CALIBRATION CURVES FOR CAs A...'\fD TIQs 
Calibration curves were constructed for DA, NE, E, salsolinol 
and 4,6,7 trihydroxy TIQ on 5% GE XF-1105 following HFB anhydride/ 
acetonitrile derivatization. The curves in Fig. 9 are the averages 
(S.D. = 8.5%) of twelve sets of these calibration experiments. 
Injection of a constant volume (1 ul of series of dilutions of 
standards) resulted in peak heights proportional to the concentra-
tions. Such linearity could hardly be demonstrated with injection 
of increasing volumes of a single standard. Upper limits of lin-
earity ranged between 200-500 pg depending on the substrate. This 
upper limit was lowest for those compounds which demonstrated the 
highest EC responses. The calibration curves (not shown) for HFB-
derivatives of a-methylated catechols, 3-methoxy-tyramine, metane-
phrine, normetanephrine, 6-methoxy-4-7-dihydroxy-TIQ (#7 in Fig. 5 ) 
and l-methyl-6-methoxy-7-hydroxy-TIQ Ui=8 in Fig. 5) were also 
prepared using the same conditions as the catechol calibration curves 
and were found to be linear up to 400-800 pg, depending on the sub-
strate amine. 
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Table 3 
A comparison of retention times and relative EC/GC sensitivities of fluoroacyl derivatives of ~HP on 
different liquid phases1 
PFP-THP 
Stationary Phase Retention Time(min) Sensitivity2 
3% OV-17 7.40 5.2 
5% SE-54 11.10 2.5' 
3% SE-30 13.30 2.5 
1cc Condition: Flow rate, 30 ml/min; column temperature, 190°C, 
2ng amines which give 50% deflection at 4 x 10·10 AFS 
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HFB-THP 
Retention Time(min) Sensitivity2 
8.55 4.0 
16.10 2.0 
--
40 
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e Norepinephrine (NE) 
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t::i.. 4,6,7-trihydroxy-TIQ 
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Fig. 9.EC/GC calibration curves for NE, E, the HCl salts of DA and 4,6,7, 
trihydroxy-TIQ, and the HBr salt of salsolinol 
GC conditions: 5% GE XF-1105; column temp. 175°c, N2= 35 ml/min 
. Att.=4 x 10-10 AFS 
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C. ExrRACTION AND RECOVERY 
The extraction procedure described in experimental Fig. 6 
involves the adsorption of catechol compounds on Al 2o3 and their 
elution with hydrochloric acid. This is a modification of the 
method studied in detail by Anton and Sayre (89). 
Previously it was found (53) that 100 mg activated aluminum 
oxide was optimum for EC/GC determination (HFB-derivatives) of 1 mg 
CA or TIQ in aqueous solution. In these experiments this amount·was 
determined to be adequate for the extraction of a pair of rat 
adrenal glands or of one brain sample. 
The highest recovery was obtained when elution of tissue CA 
mixtures with added 14c-DA or 14c-NE was carried out with 0.1 N HCl 
and when derivatization followed the lyophylization of eluant (table 
4). "Direct derivatization" involving HFB anhydride/accto:-iit:rile 
treatment of catechols in the alumina-bound state was an alternative 
acid-free procedure developed in M.S. degree research (53). Those 
original studies with non-radioactive substrates indicated that 
recoveries were adequate. However, recent experiments with 14c-
substrate showed that overall recoveries by direct derivatiz2t:ion 
were about 10% (Table 4). This direct derivatization method was not 
improved or utilized further for tissue studies. 
When aliquots of brain homogenate containing increasing asounts 
of added NE, DA, salsolinol and 4,6, 7-trihydroxy-TIQ (tb4 in Fig.5) 
were carried through the entire procedure of adsorption on aluminum 
oxide and elution with 0.1 N HCl, followed by derivatization, the 
calibration curves very similar to Fig.9 were obtained.Recoveries 
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Table 4 
% Recovery (mean ~ S.D.) of 14c-CAs1 following activated A1 4o3 extraction and derivatization with HFB~ 
anltydride/acetonitrile 
14C-DA 
14C-NE 
14C-E 
1 
Direct derivatization of 
lyophylized, Al?03-bound CAs No acid elutio~· · 
9.05 + 0.80 (3)* 
15.25 + 0.65 (3) 
11.46 + 0.56 (3) 
Elution of CAs from A1 203 with 0.1 N HCl, lyophylization, and deriva-
tization 
CAs added to rat 
CAs in lN HC104 brain homogenate 
58.9 : 2.8 (3) 
87.1 t 1.0 (3) 
42.9: 4.1(9) 
75.2 ±10.2(10) 
14 • 
C-CAs purified on A12o3 prior to.· their addition to aqueous solution or homogenate 
* Number of detenninations 
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(foi:: 14c-CAs) ft'ant tissue agree with those from 1 N HC104 solution 
(Table 4). 
D. EC/GC ESTIMATION OF CAs IN TISSUE 
I. BRAIN 
The whole brains of four rats each analyzed on two different 
columns (5% GE XF-1105 and 5% SE-54). In Table 5 are shown our 
results of these analyses, compared with the values determined by 
other investigators using EC/GC and spectroflurometric methods. 
II. ADRENAL GIANDS 
The CA concentrations in the adrenal glands of four rats, deter-
mined on 5% GE XF-1105, are shown in Table 6. Our findings (Table 
6) are compared with the results reported by Imai et al (95), who 
also used an EC/GC method (TFA derivatizations).Literature values 
for adrenal E determined spectrofluorometrically, somewhat higher 
than EC/GC values, are also included in Table 6. 
E. BLOOD ETHANOL AND ACETALDEHYDE LEVELS IN VIVO 
I. CALIBRATION CuRVES 
A Porapak QS column in a Barber Coleman 5320 flame ionization GC 
was employed for the estimation of AcD and ethanol concentrations. 
Using the microtechnique described in Experimental, two different 
calibration curves were prepared on Porapak QS, one for AcD con-
centrations ranging between 0.5-5 ug/ml and a second curve for AcD 
concentrations ranging from 10-80 ug/ml. A carbosieve-B column in 
the Varian 2100 GC was unresponsive to low AcD levels but showed 
sensitivity to the relatively high AcD levels (10 ug/ml blood). 
Therefore, Carbosieve-B was used only to verify blood AcD identity 
-44-
,, 
Table 5 
Comparison of EC/GC and spectrofluorimetry (SF) estimations of CA concentrations in whole rat brain 
Method ug/g tissue !' s D N •• 
NE DA 
EC/GC on 5% SE-54 * 4 
EC/GC on 5% GE XF-1105** 4 
EC/GC on 2% GE XF-1105 5 
SF 10 
SF 
0.55 ~ 0.08 
0.46 t 0.08 
0.57 
+ 0.45 - 0.01 
+ 0.45 - 0.01 
+ 0.90 0.07 
+ 0.99 - 0.09 
0.81 
+ 1.00 - 0.08 
0.96 + 0.01 
* GC conditions: column temperature, 1600C;N2 flow rate, 30 ml/min 
** GC condition : column temperature, 175°C;N2 flow rate, 35 ml/min 
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Reference 
this dissertation 
this dissertation 
(95) 
(96) 
(97) 
Table 6 
Comparison of EC/GC and spectrofluorimetry (SF) estimations of CA concentrations in rat adrenal glaQds 
1'_ ___ 
ug/g tissue - S.D. 
Method N NE DA E Reference 
EC/GC 4 173 ± 35 11.0 t 2 504 ± 66 this dissertation 
EC/GC 7 190 4.6 520 (95) 
SF 10 160 ± 6 899 t 65 (102) 
SF 10 254 t 16 951 t 50 (96) 
*: GC conditions: 5% GE XF-1105; column temperature, 175; ~2 flow rate, 35 ml/min 
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in pyrogallol/ethanol rats. Fig. 10 shows Porapak calibration curves 
(S.D. ± 11.5%) prepared for the estimation of blood AcD. 
II. BLOOD ETHANOL AND ACETALDEHYDE LEVELS DURING PYROGALLOL/ACUTE ETHANOL 
METABOLISX 
In two separate experiments, blood AcD levels in pyrogallol pre-
treated, ethanol injected rats were estimated and compared to the levels 
in rats treated with ethanol only. Fig. 11 shows the concentrations/ 
time curves of AcD in these two ethanol groups. 20 min after i.p. 
+ I 
ethanol, the AcD blood level in "ethanol only" rats was 2.8 - 0.9 ug/ml. 
In the pyrogallol/ethanol group the concentration of AcD at this time 
was potentiated to 41 ± 12 ug/ml blood and remained elevated after five 
hours. Thus, pyrogallol pretreatment elevates ethanol derived AcD ca. 
10-15 fold, in agreement with other work in this laboratory (105). 
Blood ethanol in both groups was determined 20 min after i.p. 
ethanol and found to be elevated slightly but non-significantly in the 
pyrogallol/ethanol group; 2.40 + + 0.68 mg/ml compared to 1.95 - 0.52 
mg/ml in "ethanol only" rats. 
III. BLOOD ETPANOL AND ACETALDEHYDE LEVELS DURING CHRONIC ETH.c\?:OL 
MEIABOLISi·1 (INTUBATION) 
An estimate of blood ethanol and AcD in rats chronically intubated 
with ethanol (the alcoholic rat experiment) was obtained on 
the 15th and last day of intoxication, 2 hr before sacrifice (5-6 hr 
after the last ethanol intubation at 0900 hr). The average values 
+ + 
of 3.9 - 0.9 ug/ml and 1.6 - 0.75 mg/ml for blood AcD and ethanol, 
respectively, were obtained for six rats, agreeing with the results 
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of Majchrowicz (77). The results are compared with literature 
values in Table 7. 
F. ACUTE ETHANOL METABOLISM 
I. FOLLOWING PYROGALLOL PRETREATMENT 
a. EC/GC Analyses o.f Combined Brain Parts (brain stem, caudate 
nucleus and midbrain, including hypothalamus) 
Fig. 12, Chromatogram A, is a normal GC chromatogram ( on 3% OV-
17) of the combined brain parts from a control (pyrogallol/saline) 
rat. The consistent appearance of a component (hatched peak) with a 
retention time identical to salsolinol, the TIQ derived from DA and 
AcD, was observed in the brain parts. of each pyrogallol/ethanol-
treated rat (Chromatogram B), and was not observed in control sam-
ples. This new component was clearly augmented when HFB-salsolinol 
was added to the GC injection solution (Chromatogram C, Fig. 12). 
The proof that this new compound did not result from reaction of 
AcD during workup is supported by its absence from control brain 
samples to which was added AcD (100 ug/ml) during homogenization. 
Further more, the retention times of several catechol compounds 
·which possibly could be present in the experimental brain and could 
contribute to this peak agreeing with salsolinol were determined. 
Table 8 shows that the HFB-derivatives of these compounds have 
retention times quite different from salsolinol and the new compo-
nent in the experimental brain parts. 
To further verify the identity of salsolinol in the brain parts 
of pyrogallol/ethanol animals, the experiment was repeated a fourth 
time with nine rats. Combined brain part extracts were derivatized 
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Toble 7 
Blood ethanol and AcD concentrationsl in the rat and human during chronic ethanol intoxication 
Subject Route of Amount/day Duration of Range Reference 
ingestion (g/ ~) intoxication (day&\ Ethanol (mg/ml) AcD(ug/ml) 
rat gastr;ic intu ation 8-12 15 120-350 2.7-5.1 this dissertation 
rat gastric 12-15 8 50-300 L0-3.0 (77) 
intubation 
human free drinking 32 ounce of '7-10 100-400 1.0-2.5 (98) 
50% grain 
ethanol 
1. Determined by different GC methods 
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LEGEND FOR FIGURE 12 
EC/GC chromatogram of the HFB-catechol-containing 
compounds in the combined brain parts of pyrogallol-
treated rats following acute ethanol intoxication 
(chromatogram B) or saline (chromatogram A). 
Chromatogram (c) shows the addition of 50 pg authen-
tic HFB-salsolinol to the chromatogram (B) injection 
solution. 
GC conditions: 3% OV-17 on 80/100 Gas Chrom Q; coluum 
temp.=160°c; N2 , 30 ml/min. Att. 2 x 10-lO AFS, 
except for DA in the control, which is 4 x io-10 AFS 
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Table 8 
Comparison of EC/GC retention times 1 of known catechol compounds to the unknown component detected in 
CA-rich brain parts of pyrogallol/ethanol rats 
Compound (HFB-derivative) Retention time (min) 
Unknown substance in experimental brains 6.45 
Salsolinol 6.45 
Epinine 3.50 
N-acetyl-DA 2.75 
3, 4-dihydroxy phenyl glycol 1.50 
3, 4-dihydroxy phenyl ethanol 1.30 
3-methoxy-catechol 1.30 
Pyrogallol 1.00 
l 3% OV-17; column T, 160°C; Flow rate, 30 ml/min 
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with PFP-anhydride in acetonetrile and were analyzed on SE-54. A 
component (shaded peak, Fig. 13) with a retention time identical to 
PFP-salsolinol was observed in each experimental (pyrogallol/ethanol) 
brain sample (h=5) but was not observed any of four control brain 
parts. Addition of authentic PFP-salsolinol to experimental sam-
ples increased the height of this new peak. 
In Table 9 the effect of acute ethanol (7 hr metabolism) on the 
CA concentrations and salsolinol formation in the combined brain 
parts of rats treated with pyrogallol is shown. The concentration 
of salsolinol in the brain parts of all experimental rats averaged 
+ from samples (three experiments) was 17 - 5.3 ng/g combined brain 
parts. As the data shows, DA and NE concentrations in the combined 
brain parts of pyrogallol rats were depressed 45-55% and 30-40%, 
respectively,by the ethanol treatment. 
Interestingly, the presence of a substance identical to E in the 
brains of all pyrogallol-treated animals was noted (Table 9) when 
bra.in extracts were analyzed on 5% GE XF-1105 for CA quantitation. 
+ Assuming this material is E, a higher concentration (83 - 20 ng/g 
brain parts) was seen in the experimental rats than in the control 
(66 t ng/g brain parts), but the increase was not statistically 
significant. 
Another interesting finding was the fact that an unidentified 
component with an unusually long retention time (LRT) on GE XF-1105 
of 60-70 min ("LRT"component), observed in all brain samples from 
pyrogallol/saline controls, was nearly absent from all pyrogallol/ 
-54-
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EC/GC chromatogram of the PFP-catechol-containing co:T;icunds 
in the combined brain parts of pyrogallol-tre2ted, acute 
ethanol- injected i::ats. Hatched peak ide.ntical to auti-1.antic 
PFP-salsolinol is absent from brain parts of saline co~trol 
rats. 
GC condition : 5% SE-54 on 80/100 Gas Chrom Q; Column Te:"'.lp .=: 160°c, 
N2 - 30 ml/min, Att.= 2 x io-lOAFs 
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Table 9 
Effect of acute ethanol on salsolinol formation and CA concentrationsl in combined brain parts 2 of 
pyrogallol-pretreated rats 
+ Experiment 3 ug[g tissue - S.D. No. Drug Treatment DA NE E Salsolinol 
1 Pyrogallol/saline (4) + + + not de_fectable 1.92 - 0.21 0.80 + 0.09 0.06 + 0.01 
Pyrogallol/ethanol (5) 0.87 t 0.39">'• 0.63 - 0.20 0.07 - 0.01 0.018 - 0 •. 009 
2 Pyrogallol/saline (6) + + not detectable 1. 98 - 0 .17 0.98 - 0.16 
-- --
Pyrogallol/ethanol (6) i.os t 0.15·:: 0.63 t 0.07 
-- --
0.017 t 0.004 
Pyrogallol/saline (5) + + + 3 2.06 - 0.26 1.02 - 0.15 0.06 - 0.01 not detectable 
Pyrogallol/ethanol (7) 1.06 t 0.10•'( 0.60 t 0.07* 0.08 t 0.02 0.015 t 0.003 
1. Values are corrected for recoveries based on 14c-DA recovery (range: Exp. 1, 42.3% - 50.1%; Exp.2, 
39.8% - 47.5%; Exp. 3, 40.9% - 53.0%) 
2. Combined brain stem, caudate nucleus and midbrain including hypothalamus 
3. Number of rats/group in parenthesis 
* p < 0.01 compared to the pyrogallol/saline control 
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ethanol brain samples. Although k could not be quantitated, this LRT 
component in the controls was a significant component iri the HFB-
derivatized extracts, as judged by the area of its peak (70% deflection) 
-10 at 8 xlO AFS. 
b. EC/GC Analysis of Adrenal Glands 
EC/GC qualitative results of adrenal glands of rats treated with 
pyrogallol/ethanol, obtained on 5% GE-XF-1105, are presented in Fig.14. 
A new (shaded) peak on the chromatograms, with a retention time iden-
tical to the major E-derived TIQ,gigantinol, was observed in all 
adrenal glands from 18 experimental rats (pyrogallol/ethanol) but not 
in adrenals from control (pyrogallol/saline) rats. This peak was 
potentiated when the HFB-d.erivative of gigantinol from E/AcH reaction 
mixtures was added to the injection solutions. The average estimated 
concentration of biosynthesized gigantinol in 13 paiisof adrenal 
glands (three experiments) was 3.7: 0.49 ug/g tissue, corresponding 
to ca. 1-2% of the E levels in the experirn.ental animals. 
E levels in adrenal glands underwent significant changes due to 
pyrogallol/ethanol, as they decreased by 50-60% (Table 10). A non-
significant 10/~ decrease, but nevertheless a definite trend, was also 
observed in NE. Conversely, DA levels were slightly increased, but 
this change was not significant. 
II. FOLLOWING PARGYLINE-PYROGi\LLOL PRETREATMENT 
a. EC/GC Analysis of Combined Brain Parts 
The combined brain parts of rats treated with two doses of 
pargyline, 24 hr and 1 hr prior to the acute pyrogallol/ethanol or 
pyrogallol/saline administration, were analyzed for HFB-salsolinol 
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Fig. 14. EC/GC chromatogram of the HFB-catechol containing compounds in 
the adrenals of pyrogallol-treated, acute ethanol-intoxicated 
rats. Hatched peak identical to authentic HI'B-gigantir,ol is 
absent from adrenals of saline control rats. 
GC conditions: 5% GE XF-1105 on 80/100 Gas Chrom Q; column temp.=175°c; 
N2, 35 ml/min; Att. = 2 x lo-10 AFS 
-58-
-~ 
Table 10 
Effect of acute ethanol on gigantinol formation and CA concentrations1 in adrenal glands of pyrogallo~ 
pretreated rats 
2 ug/g tissue - S.D. Experiment No. Dr1.1g _Tr~at_mer1t3___ -~------DA____ NE E G_igantino14 
1 Pyrogallol/saline(4) 14.4 t 4.0 190 !: 58 560 t 18 not detectable 
Pyrogallol/ethanol(5) + 119 t 48 301 ± 62* 3.7 t 0.66 14.0 - 4.9 
2 Control (5) + 146 ± 22 + not deiectable 10. 3 - 1. 7 425 - 46 
15.2 t 2.1* 125 t 18 + Experiment (7) 17'1 - 37* 4.0 - 1.05 
3 Control (6) + 168 ± 35 434 ! 41 not detectable 9.7 - 2.0 
Experiment (6) 12.5 t 3.2 138 ± 19 224 t 39* + 3.1 - 0.77 
1. The values are corrected for recoveries based on 14c-E recovery (rarige, Exp.l, 59.8% - 75.2%; 
Exp. 2, 61,0% - 69.7%; Exp. 3, 64.7% - 74.4%) 
2. The CA concentrations in exp. 3 were calculated for per g protein in addition to per g tissue a~ 
shown and the results in both cases were similar (see appendix II) 
3. Number of rats/group in parenthesis 
4. This figure at bc,st i>lwuld be considered a minimum estimate, because the aqueous E-AcD condensa-
tion itself forms 30-40% of supposedly other giganti.nol isomers (1) (which were not separable in 
GC of adrenals), and because the calibration curve used for estimation was actually based on 
quantity of stnrting amine (E) rather than on major product (gigantinol) 
* p <o.Ol colllpared to the pyrogallol/saline control 
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on 3% OV-17. The chromatograms were very similar to those from the 
pyrogallol/ethanol experiments. A component corresponding to salsol-
inol was observed (Table 11) in all pargyline-pretreated, pyrogallol/ 
ethanol rats, in significantly higher concentrations than in the 
pyrogallol/ethanol brain samples (Fig.15). The component was absent 
in the brain parts of three out of the seven rats treated with 
pargyline/pyrogallol/saline (controls) but, interestingly, the 
remaining four controls demonstrated an extremely small quantity 
(2~5 ng/g brain parts) of a component with a retention time identical 
to that of salsolinol. 
Again the large peak area due to the LRT component was present 
in the control brain samples and was significantly diminished in or 
absent from the experimental brain parts. No effort was made to 
quantify the LRT component and compare its area to other experiments. 
As shown previously in Results, EC/GC is much less responsive 
to the DA-derived benzyl-TIQ than to salsolinol. But it is reason -
able to expect the for~ation of the benzyl-TIQ in this experiment 
because MAO inhibition has been known to increase both DA and THP 
biosynthesis in vitro (10). However, when pargyline/pyrogallol/ 
ethanol brain parts were examined on 3% OV-17 at 190°c, conditiorn at 
which HFB-THP chro:natographs at 8.55 min, there was no evidence in any 
experimental samples for THP. 
Brain CA concentrations were estimated on 5% GE XF-1105. Table 
11 shows the expected increase in DA and NE levels in the combined . 
brain parts of the control pargyline/pyrogallol/saline rats (by 130% 
and 57% respectively) compared to the pyrogallol/saline control rats 
-60-. 
Table 11 
The effect of acute ethanol on salsolinol formation and the CA concentrations1 in the combined brain 
parts2 of pargyline/pyrogallol~treated rats 
Drug Treatment3 
~ug/ g tissue-!" . s. D. 
DA NE + E<+ Salsolinol 
Pargyline/Pyrogallol/ 4.44 ± 0.42 + 1.26 - 0.20 not detectable 
Saline (4) 
Pargyline/Pyrogallol/ 3.27 t o.2s~b'( 0.68 ~ 0.14* o.11a !" 0.020 
Ethanol (7) 
1 /. 
1. The values are corrected for recoveries based on .... ~C-DA recovery (range, 40.8'7'~ - 49.670). -
2. Combined brain stem, caudate nucleus and midbrain, including hypothalamus. 
3. Number of determinations 
4. The values include both NE and E because 3'/o OV-17 column does not separate these two HFB-amines. 
* p <9.01 
,·d~ p ~.001 
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in other experiments. Acute ethanol administration in pargyline/ 
pyrogallol-treated rats again led to significant depletion of CAs 
from the brain. 
b. EC/GC Analysis of Adrenal Glands 
EC/GC analysis of the adrenal glands of rats treated with 
pargyline followed by pyrogallol/ethanol administration showed the 
formation of the new catechol compound, gigantinol .. The concentra-
tion of this TIQ in adrenal glands of these experimental anirna1s 
(Table 12) was not significantly higher that its concentration in the 
pyrogallol/ethanol adrenals (Table 10). Pargyline administration also 
did not lead to a significant change in the CA concentrations in the 
adrenal gland (Table 12 vs. Table 10). Unlike brain (Table 11) acute 
ethanol metabolism did not deplete the adrenal CAs in pargyline/ 
pyrogallol rats (Table 12). 
III. FOLLOWH7G DOPA/ PYROGALLOL PRET"8.EA.r.1ENT 
a. EC/GC Analysis of Combined Brain Parts 
The quantitative determination of CAs in brain parts w2s performed-
on 5% GE XF-1105 and the results are shown in Table 13. Agreeing with 
earlier pyrogallol experiment {/:l and ://:2, Table 9, ethanol decreased 
brain DA and NE very significantly. However, DOPA administration to 
the pyrogallol-treated animals before and during ethanol metabolism 
did not prevent the depleting effect of ethanol. 
Using 3% OV-17 column, salsolinol was observed in the brain parts 
pf rats treated with DOPA/pyrogallol/ethanol (Table 13). The level 
of endogenously formed salsolinol was estimated to be 193% of the 
amount formed in the brain parts of pyrogallol/ethanol treated rats, 
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'Table 12 
The effect of acute ethanol on gigantinol formation and the CA concentrations1 in the adrenal glands 
of pargyline/pyrogallol-treated rats 
ug/g tissue t S.D. 3 
Drug Treatment2 DA ---~_L_______ E Gigantinol 
Pargyline-pyrogallol/ 
saline (4) 
Pargyline-pyrogallol/ 
ethanol (7) 
11.7 t 3.0 
+ 13.7 - 3.5 
172 t 16 
164 t 5.5 
390 t 95 not detectable 
327 t 55 + 4.0 - 1.0 
1. The values are corrected for recoveries based on 14c-E recovery (range, 66.5% - 74.0%) 
2. Number of rats/group in parenthesis 
3. This figure <::t best should be considered a minimum estimate, because the aqueous E-AcH condensation 
itself forms 30-4.0/'., of supposedly other gigantinol isomers (1) (which were not separable in GC of 
adrenals), anJ because tlte calibration cunre used for estimation was actually based on quantity of 
starting ami1w (E) rather than c1n ni:1jor pcocluct (gigantinol). 
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Table 13 
The effect of acute ethanol or DOPA/ethanol on salsolinol formation and the CA concentrationsl in 
combined brGin parts2 of pyrogallol•treated rats. 
Drug Treatment3 ' + ug/g tissue - S.D. 
DA NE E Salsolinol 
Pyrogallol/saline (5) 2.06 t 0.26 + 1. 02 - 0 .15 + 0.06 - 0.01 not detectable 
Pyrogallol/ethunol (7) + 1.06 - 0.10'"" + 0.61 - 0.07* + 0.08 - 0.02 0.015 :t 0.003 
DOPA/Pyrogallol/ethanol(6) + 1.10 - 0.26* 0.59 t 0.08* 0.0'8 t 0.01 0.029 "!: 0.015* 
14 
1. The values are corrected for recoveries based on C-DA recovery (range 39.8%-47.7%) 
2. Combined brain stem, caudate nucleus and midbrain including hypothalamus. 
3. Number of rats/group in parenthesis 
* p ~0.05 compared to pyrogallol/saline 
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althoug this increase was not statistically significant. 
b. EC/GC Analysis of Adrenal Glands 
The level of E in the adrenal glands of pyrogallol treated rats 
was decreased by ethanol similar to previous pyrogallol experiments 
(table 12), but 1-DOPA given once before and once during ethanol 
metabolism, did not prevent ethanol depleting effect on E. Further, 
it should be noted that DOPA/Ethanol treatment significantly lowers both 
adrenal NE and DA in pyrogallol rats. 
Administration of 1-DOPA did not have a significant effect on the 
concentration of the biosynthesized E-derived TIQ (gigantinol) in the 
adrenal glands of pyrogallol/ethanol treated rats (Table 14). 
IV. FOLLOWING RESERPINE/PYROGALLOL PRETREATMENT 
Rats treated with reserpine (2.5 mg/Kg i.p.) could not tolerate 
the following day's acute pyrogallol/ethanol treatment. All seven 
experimental rats died within 15~45 minutes after the first ethanol 
injection. The intention of this experinent was to deplete the tissue 
CAs and to observe the effect on TIQ biosynthesis. The experiment was 
not repeated with a lower dose of reserpine althoug such a change 
might be adequate to ensure survival. 
V. IN THE ABSENCE OF DRUS TREATIIENT 
a. EC/GC analysis of whole brain 
The qualitative EC/GC analysis of the brains of acute (7 hr) 
ethanol-treated rats with no drug pre-treatment was performed on 3% 
OV-17 (chromatogram is not shown). In the ethanol animals there was 
no detectable evidence for salsolinol biosynthesis in whole brain; CA-
-66-
Table 14 
The effect of acute ethanol or DOPA/ethanol on gigantinol formation and the CA concentrations1 in the 
adrenal glands of pyrogallol-treated rats 
Drug Treatment 2 ug/g tissue ± S.D. 
Gigantino13 DA NE E 
Pyrogallol/saline(4) + 14.4 - 4.0 190 ± 58 560 t, 18 not detectable 
Pyrogallol/ethanol(S) 14.0 t 4.9 119 -:!:" 48 301 t 62•'<' 3.7 ± 0.7 
DOPA/Pyrogallol/ethanol(6) 8.0 :t" 3.4"0 '<- 100 :t 23* 216 ± 64•'<' + 3.3 - 1.0 
1. The values are corrected for recoveries based on 14c-E recovery (range, 57.4%- 71.7%) 
2. Number of rats/group in parenthesis 
3. This figure at best should be considered a minimum estimate, because the aqueous E-AcH condensation 
itself froms 30-4.0% of supppscdly other gigantinol isomers (1) (which were not separable in GC of 
adrenals), and because the calibration curve used for estimation was actually based on quantity of 
starting amine (E) rather than ofmajor product (gigantinol) 
<'( p <0.01 compared to pyrogallol/saUnc. 
*''( p <0.05 
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rich brain parts were not examined separately in these ~eriments. 
Again, similar to the preceding experiments with pyrogallol/ 
saline and combined brain parts (vide supra), the whole rat brains 
from controls (saline only) showed the presence of significant 
quantities of the unknown LRT component. The acute ethanol treatment 
resulted in the almost complete disappearance of the L~T component 
from the whole brain, analogous to the pyrogallol/ethanol experiments. 
The quantitative effect of ethanol on CA concentration of brain, 
evaluated on 5% GE XF-1105, is in table 15. A sw~ll and non-significant 
decrease of CAs was observed in the whole brain of ethanol-treated 
rats compared to saline controls. 
G. CHRONIC ETHANOL METABOLISM IN THE ABSENCE OF DRUGS 
I. GASTRIC INTUBATION TECHNIQUE 
In this experiment, rats were intubated two and later three ti::res 
daily for 15 days with 25% ethanol in water (v/v) or 21~~ dextrose in 
water (w/v) (Experimental, vide supra). Throughout the e::tire study 
the experimental animals were sluggish but did not shew any other 
gross behavioral changes. The first day the food inta~e for 
experimen ta.ls dropped more than 90% of the pre-ethanol fo-od levels, 
but then it gradually increased and stabilized at about 25% of this 
pre-ethanol level after five days. The pair-fed control. :.·ats shc'.:e.d 
hunger-related anxiety for the daily pellet ration, ~;hi ch had been 
determined from the experimental rat pellet consumption of the 
preceding day. Water intake ad lib 
between controls and experimentals. 
did not differ significantly 
In Fig. 16 are plotted food 
intake (experimental=controls) and body weight changes vs. tir:::e. 
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"Table 15 
The effect of acute ethanol on the DA and NE concentrations 1 in the whole brain of rats 
E . 2 xperi.ment 
Saline (control) (4) 
Ethanol (5) 
I . + ug g tissue - S.D. 
DA 
+ 0.74 - 0.15 
+ 0.61 - 0.19· 
NE 
+ 0.38 - 0.07 
+ 0.33 - 0.07 
1. The values are corrected based on the average recovery of 14c-DA in these studies (44.4%) 
2. Number of rats/group in parenthesis. 
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a. EC/GC Analysis of Brain and Adren~l CAs 
Fig. 17 shows the superimposed chromatogram of control (solid 
peaks) and experimental brain parts (dashed peaks). Evaluation of 
experimental brain parts showed no evidence for the occure..~ce of DA-
derived salsolinol during chronic intoxication. However, similar to 
the saline controls in acute ethanol experiments, the brain parts of 
these control rats (pair-fed, isocaloric dextrose -treated) showed 
the presence of theLRT component (peak at 62 min) in large quantities. 
It was nearly absent from the brain parts of chronic ethanol rats 
(dashed line at 62 min). 
In terms of potential TIQ biosynthe.sis, there was no EC/GC 
evidence on 5% GE XF-1105 for any new catechol compounds in the 
experimental adrenals. The superimposed chromatogram in Fig.18 
shows the quantitative changes in adrenals between cont:-ols (solid 
peaks) and experimentals (dashed peaks). 
The quantitative analyses of brain parts and adreLal glands are 
summarized in Table 16. 
DA in the combined brain parts was decreased 24~~ by chronic 
ethanol and was unchanged in the adrenals. NE was lowered .6.3~s in 
brain parts, and 54% in the adrenals, by the chronic ethanol ~etabolism. 
E was depleted 42% in the adrenals by ethanol. 
b. EC/GC Estimation of 0-methylated CA Derivatives in Brain 
HFB-derivatives of the O-methylated CA metabolites extracted 
from the combined brain parts of each chronic ethanol and control rat 
were determined on 5% GE XF-1105. The results (Table 17) demonstrate 
a 130% increase in the level of the DA metabolite, 3-nethoxy-tyramine, 
. 
in the combined brain parts of alcoholic rats compared to controls. 
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Fig. 17, Superimposed EC/GC chromatograms showing relative changes in HFB-catechol-containing 
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GC condition 3/'o OV-17 on 80/100 Ga~; Chrom Q , Column Temp.=160 C; N2 flow rate 30 ml/mi 
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Table 16 
1 
The effect of chronic ethanol on the CA concentrations in the combined brain parts and adrenal 
glands of rats 
CA ug/g brain2 ± S.D. ugLg adrenals3 + - S.D. 
control ( fj. y'; chronic ethanol (7) control(4) chronic ethanol(7) 
0.93 t 0.10 0.68 + O.OS-io'<- 21.3 + 3.0 17.8 + 3.6 DA 
- -
+ + 192 + + NE 0.53 - 0.08 0.30 - 0 .02'"/d: 45 89 
-
16** 
E 550 + 91 344 + 36** 
-
1. Combined brain stem, caudate nucleus and midbrain,including hypothalamus. 
2. The values are corrected based on the average recovery of 14c-DA in earlier experiments 
3. The values are corrected for recoveries based on 14c-E recovery (range 65.3%-70.6%) 
'"/c Number of rats/ group 
*"c p < 0.01 compared to control 
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Table 17 
Tl1e effect of chronic ethanol on 3-rnethoxy-tyramine and nonnetanephrine concentrations in the combined 
brain partsl of rats. 
Drug Treatrnent 2 ug/g tissue + S.D. 
3-rnethoxy-tyrarnine normetanephrine 
Dextrose solution (4) 244 t 34.4 126 + 8,6 
Ethanol solution (7) 560 + 75.0* 
1 Combined brain stern, caudate nucleus and midbrain including hypothalamus 
2 Number or rats/group in parenthesis 
,'<: P<0.01 
*,'<: p<0.05 
compared to dextrose control 
compared to dextrose control 
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The increase in NE metabolite, nortnetanephrine, was smaller (24%) 
but was still statistically significant. 
II. CHRONIC i.p. INJECTION TECHNIQUE 
As stated in Experimental, this experiment was terminated due to 
animal deaths. After the first day the food intake of experimental 
rats diminished to less than 10% of their pre-ethanol levels and there 
was a corresponding rapid weight loss. After four days the.experimental 
rats developed severe diarrhea and most died within the next several 
days. No amine analyses were carried out. 
H. ACUTE METHfu"!OL METABOLISM 
I. FOLLOWING PYROGALLOL PRETREATMENT 
In this experiment rats were treated with pyrogallol one h::mr 
before the acute methanol administration described in t:1e 2:<'.'-'e::-::..:-:-,ental 
section. The blood levels of methanol and HCHO were not ~easured in 
these eh'Perimental animals. 
The EC/GC results from the qualitative analyses of brain parts 
on 5% GE XF-1105 demonstrated no detectable appearar:.ce of CA/:tC::O 
derived TIQs; therefore the chromatograms are not sho~.;n. Howe-:er, 
the LRT component was obvious in the brain parts of ooth control 
(pyrogallol/saline) and experimental (pyrogallol/~.et!-_a::2l: r=~ts; :'.. .e. 
the methanol administration did not lead to any apparent decrease in 
the unknown LRT component in the brain. 
Quantitative analyses of CAs in the brain gave different results 
from those analyses of acute ethanol metabolism experinents. The 
concentrations of DA and NE in the combined brain parts fro~ pyrogallol/ 
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methanol rats, slightly higher than the control, were not statistically 
different (Table 18); the slight increase in brain E was statistically 
significant. 
Fig. 19 is an EC/GC chromatogram of adrenals. It shows the pres-
ence of a new catechol component (hereafter, for discussion purposes, 
referred to as 1-nor gigantinol) appearing in all pyrogallol-methanol 
rats but not in any of the controls, which could be potentiated by the 
addition of the HFB-derivative of the major E/HCHO-derived TIQ to the 
GC injection solution. A second unidentified component was also seen 
in 3 of the 5 experimental adrenal glands. Its retention time was in 
vicinity of CA-derived TIQs, but did not correspond with any of the 
available compounds. 
Table 19 shows the effect of methanol on CA concentrations in the 
adrenal glands of rats treated with pyrogallol. Large and statistically 
significant depletions in adrenal E and NE (86% and 75%, respectively) 
occurred due to the methanol metabolism in pyrogallol-treated rats. 
II. IN THE ABSE~ICE OF DRUG TREA.TMENT 
As is apparent in the chromatogram, Fig. 20, acute methanol 
administration to the rats without prior drug treatment resulted in 
the fonnation of two new catechol compounds in adrenal glands. The 
first new peak corresponded to 1-nor-gigantinol, the cyclization 
product of E and HCHO. The height of this first new peak in the 
experimentals was increased when the HEB-derivative of E/HCHO 
cyclization products were added to the injection solution. The 
concentration of suspected 1-nor-gigantinol, when peak areas were 
compared, was 20-30% less than in adrenals of pyrogallol/methanol 
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'l'able 18 
The effect of acute methanol. on the CA concent:··ationsl in the combined brain parts2 of pyrogallol-
' 
3 Drug treatment 
Pyrogallol/saline (4) 
Pyrogallol/methanol (5) 
treated rats 
ug/g tissue + S.D. 
DA NE 
+ 1.92 - 0.21 + 0.80 - 0.09 
+ 2.10 - 0.24 1.02 ± 0.18'f( 
E 
0.066 t 0.008 
0.094 t 0.010* 
1. The values are corrected for recoveries based on 14c-DA recovery (range, 41.3% - 49.9%). 
2. Combined brain stem, caudate nucleus and midbrain,including hypothalamus. 
3. Number of rats/group in parenthesis 
.,._ p "<::: 0. 05 compare<l to pyroga llol/ nall.nc control 
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Fig. 19.EC/GC chromatogram of HFB-catechol containing compounds in 
the adrenals glands of acute methanol intoxicated, pyrogallol-
treated rats. Hatched peaks are absent from the adrenals of 
saline/pyrogallol-treated control rats. 
GC conditions: 5% GE XF-1105 on 80/100 Gas Chrom Q, Colunm Temp. 
175oc, N2 , 35 ml/min; Att= 4 x 10-lO AFS. 
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Table 19 
The effect of acute methanol on CA concentrations1 in the adrenal glands of pyrogallol-treated ratsi 
Drug treatment3 
pyrogallol/saline (4) 
pyrogallol/methanol (5) 
+ ug/g tissue - S.D. 
DA NE 
+ 10.4 - 2.0 
8. 2 t 2. Oi( 
+ 92.6 - 2.2 
22.7 t 3.2* 
E 
325 t 17.0 
87 t 7.0* 
1. The values are corrected for recoveries based on 14c-E recovery (range, 61.1%-73.5%) 
2. Rats weighed 550±~ in this experiment. 
3. Number of rats/group in parenthesis. 
* p< 0.01 
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Fig. 20.EC/GC chromatogram of HFB-catechol containing compounds in 
the adrenals of acute methanol-intoxicated rats. Hatched 
peaks are absent from the adrenals of saline control rats. 
EC/GC conditions: 5% GE XF-1105 on 80/100 Gas Chrom Q. Tc= 175°c 
Att.=4 x 10-10 AFS 
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rats (vide supra). 
A second newly-formed component also absent from control 
adrenals, was observed in all adrenal glands of experimental rats at 
7.'JJ min on the chromatogram (Fig.zc)). This unidentified component had 
different retention time than the second unidentified component ( 14.0 
min) in the adrenal glands of pyrogallol/methanol treated rats. 
Although its retention time was in the range of simple TIQs, it did 
not correspond to the TIQ substrates available for this study. 
In whole brain the qualitative results of acute methanol 
metabolism were approximately the same as in pyrogallol/acute 
methanol metabolism; that is, TIQ formation was not seen in the 
whole brain of methanol-treated rats. The LRT component was present 
in all brains and did not appear to be depleted by methanol 
metabolism. 
The quantitative effects of methanol on CA concentrations in 
whole brain and adrenal glands of rats are in Table 20 and 21. 
respectivelyo Similar to its effect in the pyrogallol experiment, 
methanol did not alter the brain CA concentrations after seven hours 
metabolism, but it significantly decreased adrenal E(by 68%), adrenal 
NE (by 74%) and adrenal DA (by 55%). 
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Tnble 20 
The effect of acute methanol on DA and NE concentrations1 in the whole brain of rats 
Drug treatment3 ____ _ t!g/ g tissue "±' S. D. 
DA NE 
Saline (5) + 0.55 - 0.01 + 0.13 - 0.01 
Methanol (5) + 0.48 - 0.07 + 0.12 - 0.01 
1. The values are corrected for recoveries based on 14c-DA recovery (range, 34.4%-48.2%) 
2. Number of rats/group in parenthesis. 
3. Number of rats/group in parenthesis 
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PART FOUR 
DISCUSSION AND CONCLUSIONS 
A. TIQ BIOSYNTHESIS DURING ETHANOL METABOLISM 
In three sequential experiments, each GC chromatogram (Fig.12 B) 
obtained from the combined brain parts of rats treated with pyrogallol 
followed by ethanol demonstrated a new component not observable in 
the pyrogallol/saline controls (Fig. 12 A) that had a retention time 
identical to salsolinol, the TIQ cyclization product of DA and AcD. 
HO 
HO 
SALSOLINOL 
The amount of this component was augmented when the HFB-derivative 
of authentic salsolinol was added to the injection solution (Fig.12 C). 
The possibility exists that the suspected salsolinol for~d in the 
workup was eliminated by control homogeniza~ion with added AcD. Other 
catechol compounds such as N-acetyl-DA, epinine, dihydroxy-phenyl-
ethanol, dihydroxyphenylglycol, as well as pyrogallol and its metab-
olites (3-methoxy-catechol and 2,3-dimethoxyphenol), all had reten-
tion times different from salsolinol and the new brain canpound. 
When brain DA was significantly elevated by pargyline administra-
tion to the animal prior to pyrogallol/ethanol treatment, the 
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concentration of salsolinol in brain parts also was potentiated 
above the level observed in non-pargyline, pyrogallol/ethanol rats. 
Since precursor (DA) is increased ctue to MAO inhibitiort;''higher 
levels of product (salsolinol in the high AcD environment occurred. 
Using another derivatization method and column, salsolinol was 
again observed in combined brain parts of pyrogallol/ethanol rats. 
According to Wilk and Zimmerberg (99) and others (80, 106), 
identification of an unknown compound by GC is established through 
comparison of the retention times of two different derivatives of 
that compound on two or more columns with those of "authentic" sub-
strate. Both of these techniques - varying the der~vative (HFB-and 
PFP-) and the columns (GE XF-1105, SE-54 and OV-17), including 
column temperatures - were done in order to positively identify 
salsolinol. 
In the brain of rats receiving ethanol (acute or chronic) there 
was no sign of a new component which could be salsolinol. This no 
doubt was because of the 1/8 - 1/10 lower concentrations of AcD in 
the blood (1-3 ug/ml) and tissues of these rats than those treated 
with pyrogallol/ethanol. Pyrogallol administration is 2rJparently 
the important factor in producing EC-detectable a1~-0unts of salsolinol 
in the tissues of ethanol-treated aniinals. Concerning pyro;o: llo 1' s 
effect on AcD levels, it is likely that this comes about via inhib-
Hion of aldehyde oxidation pathways (105). Thus this drug paten-
tiated the level of endogenously-formed catechol TIQ alkaloids not 
only by inhibiting the CO}IT catabolism (51, 52), but also by el-
evating the reactant, AcD (and possibly the CAs). 
-86-
·. 
Nevertheless, these findings as well as the recent demonstration 
by Sandler et al (49) ought to be encouraging to investigators in the 
field of neurochemistry of alcoholism. However, the latter study 
only demonstrates the presence of TIQs in urine without proving that 
this formation was in blood or tissue. Since DA is a normal constituent 
of urine (100,101) and AcD is probably present in urine after ingestion 
of ethanol, it is probable that such a cyclization would take place in 
the urinary tract. 
Unexpectedly, 1-DOPA injection before and during ethanol metab-
olism in pyrogallol-treated rats did not raise brain DA concentrations. 
Compared to pyrogallol/ethanol rats, only a slight but significant 
increase in salsolinol was observed. It has been shown that 1-DOPA raises 
brain DA in ethanol-intoxicated rats (109). One partial explanation is 
that condensation of 1-DOPA with AcD, present in abnormally high levels, 
forms another TIQ (3-carboxy-TIQ) and diverts 1-DOPA from its DA 
precursor role. The ease of this DOPA/AcD cyclization has been described 
by Brossi et al (43). 
l-methyl-3-carboxy 
6,7-dihydroxy-TIQ 
(3-carboxy-TIQ) 
CH 
3 
Tet~ahydropapaveroline (THP) 
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The. postulation of in vivo aldehyde condensation with DOPA is 
not without precedent. Pfeiffer and Ebadi (118) have suggested that 
a similar cyclization between DOPA artlpyridoxal phosphate takes 
place and leads to an inhibition of the DOPA-induced elevation of rat 
brain DA when the two compounds are administered together. However, 
this amino acid/AcH cyclization would have to be quantitatively 
significant in order to nullify the DA-elevating effect of DOPA. 
Alternatively, the 3-carboxy-TIQ itself may have inhibiting effects on 
DA biosynthesis or storage. According to Cohen (103),3-carboxy-TIQs 
are not decarboxylated substantially by DOPA decarboxylase. This 
would explain the relative lack of change in the salsolinol concentra-
tions, if DOPA/AcD condensation had occurred. 
THP, a more complex DA-derived TIQ alkaloid (above),is reported 
to be found in rat brain homogenate incubated with DA and ethanol or 
AcD (104), and in the urine of Parkinsonian patients (49). THP was 
not detected in the brain parts of pargyline/pyrogallol/ethanol rats. 
However, the very low EC sensitivity of HFB-THP (:,IDQ=2JOpg) would 
require that 100-200 fold more THP than salsolinol be biosynthesized 
in brain. Thus THP tissue biosynthesis could have occurred to a much 
greater extent than salsolinol biosynthesis in these experiments and 
still would be undetectable by the EC/GC method. Mass fragr:entography 
would be more helpful than EC/GC for the detection of HFB-THP. The 
relatively high concentration of peripheral DA in Parkinsonian patients 
treated with 1-DOPA no doubt was significant in facilitating the 
formation of THP in urine or tissue (49). 
NE/AcD•derived TIQ was not observed in brain of experimental 
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rats either. Several reasons may account for this. Fig. 8a shows 
clearly that the EC detector response to this TIQ is about 10-15 times 
less than to salsolinol. Furthermore, the velocity of reaction 
between NE and AcD is about 1/8th that of the DA and AcD reaction. 
. ( . -1 -1 Robbins (47) found the second order rate constant l:J..ter mol min ) 
for alkaloid formation (pH 7.4 at 37°c) between AcH and DA, 1-DOPA or 
NE to be 15.3, 6.1 or 1.9 respectively. Finally brain NE concentration 
is over 50% less than DA. 
As stated previously, ethanol metabolism in the "chronic alcoholic" 
rat did not result in detectable amounts of brain salsolinol. However, 
one major and possibly important difference was obvious between the GC 
chromatograms of control rat brain tissues and the chromatograms of 
brain tissue from chronic alcoholic as well as acute alcohol-treated 
rats (Fig.17 ). This was the existence of relatively large amounts of 
long retention time (LRT) component only in the controls. The 
identity of this component which is so rapidly depleted by ethanol 
ramains undetermined, since this study was concerned primarily with 
TIQ biosynthesis. As a suggestion, the LRT component may be a volatile 
derivative of cofactor, NAD, which is depleted during ethanol metab-
olism. Consistent with this is the result that methanol, which is 
thought to be metabolized in the rat via hepatic catalase (107), did 
not lead to the disappearante of this unknown peak. However, the low 
activity of NAD-dependent aldehyde dehydrogenase in brain, as reported 
by Raskin and Sokoloff (108), does not support this suggestion. 
Polyhydroxy steroids, when derivatized with HFB-groups, may have 
long retention times. The LRT component may be such a normal brain 
steroid which is depleted by ethanol or its metabolites or by some process 
-89-
'• 
activated by ethanol, such as CNS transport (141). No EC/GC comparisons 
were done of retention times of HFB-derivatized NAD or any other normal 
brain material to the LRT component in nonnal rat brain. 
TIQ biosynthesis in adrenal glands of pyrogallol/ethanol rats was 
also observed. The experimental animals demonstrated the presence of 
a new adrenal catechol derivative which was absent in pyrogallol/saline 
controls. This component could be augmented by the addition to the 
injection solution of the HFB-derivative of gigantinol (l,2-drmethyl-
4,6, 7-trihydroxy-TIQ). 
OH 
GIGANTINOL 
Pargyline pretreatment did not affect the quantity of biosynthesized 
gigantinol in the a:lrenal glands. Tne reason that this drug acted 
differently between brain and adrenal gland is not clear but may involve 
the possible specific effects of pargyline on different HAO isoenzymes 
(110,111,112,113). Selective inhibition of ~!AO action on different 
substrates las been reported by several investigators (112,114). Zeller 
(115) noted the differences in potency of pargyline as an MAO inhibitor, 
depending on which substituted benzylamine was used as a substrate. 
Squires (116), studying the selective action of various inhibitors on 
MAO in different organs of animals, suggested the presence of two ~·!AO 
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fra~tions, A and B, in varying ratios in different tissues. It was 
shown that pargyline selectively in~ibits the B fraction (116) of 
MAO in most species. To our knowledge no investigation has been 
carried out on the types of MAO in the adrenal glands. It is possible 
that A/B ratio of MAO is tmJch larger in adrenal glands than brain, 
therefore making MAO les sensitive to pargyline inhibition. Never-
theless, 90% inhibition of MAO enzyme apparently is required (117) 
to fully observe elevation in CA levels. These findings may 
describe in part why changes were not observed in adrenal CAs and 
gigantinol due to pargyline administration, while significant in-
creases were observed in brain DA and salsolinol concentrations. 
The effect of 1-DOPA on the level of E and gigantinol in adre-
nals of pyrogallol/ethanol rats was insignificant. As mentioned 
above in Discussion, it is possible that the normal metabolic pathway 
of DOPA-DA in the presence of high AcD concentration is diverted to 
the formation of 3-carboxy-TIQ. This TIQ might be exerting an inhib-
itory effect on CA metabolism at the decarboxylase stt:?, or interfer-
ing with CA storage in chromaffin cells. 
B. TIQ BIOSYNTHESIS DURING HETHA2WL HETABOLISM 
Acute alcohol intoxication experiments also were carried out with 
methanol. The metabolite,formaldehyde (HCHO) condenses with C.\.s in 
vitro 25-50 times faster than AcD (1), and therefore TlQ iorT'l2.tion 
might be expected. Administration of methanol to untreated or 
pyrogallol-treated rats resulted in a new adrenal product with an EC 
/GC retention time agreeing with 1-norgigantinol (the simple TIQ 
derivative of E and HCHO). TLC evidence for adrenal norgigantinol and 
.the NE/HCHO-derived TIQ has been reported(45).In these present exper-
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iments there was no indication of the NE/HCHO derived alkaloid in 
adrenals. 
Pyrogallol administration did not increase the concentration of 
suspected 1-norgigantinol in the adrenals. The level of blood HCHO 
in rats after treatment with methanol or pyrogallol/methanol was not 
determined. Apparently pyrogallol does not inhibit the catalase 
system (105) which is responsible for methanol metabolism in rat(l07~ 
Therefore, HCHO level, unlike AcD, would not be expected to be 
increased by pyrogallol, and detectable TIQ concentrations would 
depend only on the COMT inhibitory effect of pyrogallol. 
A scond new compound in the range of TIQ and CA retention times 
with a peak area about 25% less than that of 1-norgigantinol consist-
ently wa.s seen in the chromatograms of the adrenals from rats treat-
ed with methanol only (Fig. 20, page 81). The possibility exists that 
this was another oxidized catechol metabolite of 1-norgigantinol or 
the TIQ derived from ~:E, but due to the lack of authentic substrates, 
this idea could not be checked out. However, it is perhaps signif-
icant that pyrogallol pretreatment caused this second unidentified 
adrenal compound to disappear (or change) concomitant with the for~~­
tion of another new "second" peak still within the range of TIQs and 
CAs at 14.0 min (Fig. 19, page 79). 
It is possible that both new "second" peaks are E-derived TIQ 
products from two different catabolic pathways, one significant and 
the other normally insignificant. Pyrogallol may cause a,metabolic 
shift towards the nonnally insignificant pathway. It is also possible 
that pyrogallol somehow affect the E/HCHO cyclization reaction lead-
ing to a different isomeric product. 
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An alternative explanation is that the new "second" adrenal 
peaks in methanol and pyrogallol/methanol rats are CA rather than 
TIQ metabolites, 3-methoxy-4-0H-phenylglycol (MHPG) and dihydroxy-
phenylglycol (DHPG), respectively. MHPG, considered to be the major 
catabolite of brain NE (134, 139), may be a minor catabolite in the 
(control) adrenals. Methanol metabolism, by increasing the reductive 
capacity of adrenal tissue, might increase MHPG concentrations 
sufficiently so that MHPG would be carried over or extracted by the 
Al
2
03 procedure. Inhibition of C0}1T by pyrogallol would decrease 
MHPG and increase its precursor, DHPG, perhaps to detectable concentra-
tions. Further work is necessary in order to identify these new 
components in the adrenals of methanol-intoxicated rats. 
It is puzzling that; contrary to the adrenal situation, there 
was no GC evidence for TIQ biosynthesis from the condensation of 
brain CAs with HCHO in the methanol-intoxicated rats (with or without 
pyrogallol). Due to the high reactivity of HCliO with DA (119) it is 
possible that some kind of condensation reaction may have taken place 
but metabolism of the TIQ (1-norsalsolinol) occurred during the 8 hr 
experimental time. Time studTes should be performed to follow up this 
suggestion. 
C. CA. Concentrations in i\ormal Rat brain and Adrenal Glands 
It is known tha HFB-derivatives of biogenic amines show larger 
E.C. responses than their TFA-and PFP-analogues (83, 123). In addition, 
because of longer retention times, HFB-derivatives sometimes demonstrate 
better GC resolutions. These aspects were used to separate HFB-TIQs 
from the HFB-CAs in pg amounts. Although the% recovery was lower 
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than the Arnold and Ford method (83), the reproducibility for 
catechol compounds and their metabolites was excellent. The applica-· 
tion of 14c-tracers was used to determine total losses from tissue 
during the purification steps and corrections for this loss served 
for the precision of results. The precision obtained from repeat 
estimations of CAs in the brain parts of pyrogallol-treated rats 
(Table 22), demonstrates the reliability of th.is EC/GC technique in 
tissue analyses. 
This technique was used successfully for the analysis of less 
than 10 mg of brain tissue and for the recovery of as little as 10 ng 
of added 4,6,7-trihydroxy-TIQ with tissue DA and NE. DA, NE and E 
concentrations were also estimated in the whole brains of individual 
rats and the results (Table 5, p 45) compared favorably with the 
spectrofluorometric analyses of Shellenberger and Gordon (97) and 
Barchas et al (96). 
In this EC/GC technique, the small difference obserbed between 
the values of brain NE on two different columns (Table 5, p 45) could 
be due to the lack of separation of NE from E on SE-54 (or OV-17) as 
opposed to GE XF-1105. 
The concentrations of CAs in adrenal glands of normal rats were 
found with HFB-derivatives on GE XF-1105 to be in close agreement 
with the_GC results reported by Imai et al (95). Concentrations of 
adrenal E measured by spectrofluorometric methods are higher than that 
determined by GC methods (Table 6, p 46). This diversity could be 
due to the strain differences in experimental animals, or to inter-
ference of non-specific materials with the spectrofluorometric method. 
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Table 22 
Comparison of the results obtained from repeat estimation of CAs in the combined brain parts of 
pyrogallol-treated ratsl 
ug/g tissue2 t S.D 
ExEeriment No. No. of rats DA NE E 
1 4 + 1.92 - 0.21 + 0.80 - 0.09 0.063 t 0.009 
+ + + 2 6 1. 98 - 0 .17 0.99 - 0.11 0.080 - 0.016 
3 5 2.06 ! 0.26 + 1.02 - 0.15 0.058 ! 0.010 
4 5 + 2.02 - 0.50 + 1.05 - 0.31 
1 control rats for acute ethanol metabolism experiments, Experimental, p.32 
2 the values are calculated_ per g combined brain parts (brain stem, caudate nucleus and midbrain, 
including hypotbalamus) 
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The r:esults from pyragallal-treated rats indicate the existence 
of E in the rat brain. The presence of E in the CNS has been a matter 
of controversy. Since the suggestion was made by Von Euler (124) that 
E (sympathin) exists in mammalian brain, many investigations have been 
made on the problem. The ratio of E to the sum of E and NE in rat 
brain was reported to be 0.045 by Gunne (125) 0.034 by Montagu (126), 
determined by fluorocetric methods. On the other band, Sano and 
Taniguchi (127), using Amberlite IRC 50 for the separation o_f' CAs, 
and the trihydroxyindole fluorometric method, found no E in the brain. 
Carlsson (128) and McGeer and McGeer (129) also failed to detect this 
amine by fluorometry. Anton and Sayre (89) conjectured that the large 
amount of DA in the brain may interfere with the fluorometric meas-
urement of E. Imai et al (95) with EC/GC and TFA derivatives, have 
raeasured 150 ng E/ g of whole rat brain. As shown in Table 9, p56 
the average concentration of E in the combined brain parts of pyrogallol-
treated rats was 66 -:!:: 8 ng/g tissue, which is about 6.6% of the NE + E 
concentrations in the same brain sample. The possibility exists that 
circulating E in blood contributes to this "brain E" value. However, 
the small quantity of blood within the brain at decapitation with an 
E concentration of 60 ng/L ( 102) could not contribute more than 50-100 
pg E to the average value. 
E was not estimated in brain samples from !l2!l-pyrogallol-treated 
rats(contro~. One reason for this was that in the whole rat brain 
analysis a relatively large unknown peak tended to overlap with the 
retention time of HFB-E on GE XF-1105. It was for this reason, in fact, 
that organic solvent extraction (91), in case the interfering component 
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was lipid, "WaSi att:elllp'ted; in one. experiment (Experimental, vide 
supra), but with little success. In combined brain parts this 
component interfering with E, although diminished, was still appar-
ent. Pyrogallol pretreatment served to potentiate brain E (perhaps 
due to inhibition of CO}!T catabolism) and permit its estimation in 
saline controls. 
D. THE EFFECT OF ALCOHOL METABOLISM ON RAT BRAIN Ai.1' ADRENAL CA 
CONCENTRATIONS 
Conflicting data on the effect of ethanol on brain amine 
concentrations has been reported (Introduction, vide supra). This 
discrepancy has been attributed by some to ethanol-derived AcD, caus-
ing the release of CAs from the CNS(26,34). In this study, acute 
ethanol metabolism in the absence of other drugs did not change brain 
or adrenal CA concentrations, in agreement with Haggendal and 
Lindquist(31) and others (30). However, sharp decreases in the 
respective CAs to ca. 50% of control brain DA and NE and control 
adrenal E concentrations were observed when the acutely intoxicated 
rats were pretreated with pyrogallol. Because blood AcD levels dur-
ing ethanol oxidation were elevated by pyrogallol, the decreases in 
CAs probably reflect in part or in total the releasing action of 
AcD on CA stores. 
Chronic ethanol metabolism for 15 days(in the absence of other 
drugs), however, which generates an "alcoholic" rat(77), did result 
in significant 25-50% decreases in brain DA and NE and adrenal E. 
Thus when control rats are properly handled, and paired nutritionally 
.with experimental alcoholic rats, changes in CA due to "alcoholism" 
become apparent. The lack of adequate nutritional controls may 
explain why some investigators reported no brain amine cbanges fol-
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lowing chronic ethanol gavage in the rat (33). Furthermore, the deple-
tion observed here may be due as much to the chronic presence of AcD 
(estimated at 4 ug/ml at sacrifice) as to ethanol. 
Alternately, the data from methanol metabOlism experiments in-
dicate. that HCHO-derived TIQ may be involved in the CA depletion process. 
In adrenals, which were shown to possibly contain TIQ(s) derived from 
E, significant depletion of E and NE was seen, whereas in the same rat, 
no TIQs and no CA decreases were observed in the brain. 
The mechanism by which HCHO-derived TIQs might lower CA concentr&-
tion is speculative. Cohen has shown that DA/HCHO cyclization products 
release and inhibit the uptake of CAs in vitro (55, 130). It is possible 
that certain TIQs can displace CAs from storage and receptor sites. 
Tabakoff et al (132) have reported that salsolinol and morphine easily 
displace 5-!IT from its "binding site" in brain tissue. Perhaps TIQs act 
on membrane as has been suggested for 6-hydroxy-DA (131) to increase 
permeability to or block the uptake/storage of CAs. The striking struc-
tural similarity, shown in Fig.21, between a possible quinoid oxidation 
product of DA/HCHO-derived TIQ and the hypothesized active quinone from 
of the in vivo CA depletor, 6-hydroxy-DA (133) suggests a mechanism by 
which the TIQ itself could lower CA levels. Pharmacological wor:.C is 
necessary with the synthetic TIQ. 
As DA and NE in brain during chronic ethanol consun~rtion are 
decreased by whatever mechanism, one expects an increase in 3-methoxy-
tyramine and normetanephrine, metabolites produced by the action of 
extracellular COMT on the amines. In fact, this proved to be the case. 
Brain parts of rats chronically treated with ethanol were analyzed 
to estimate the level of 0-methylated metabolites of CAs. Substantial 
increases of 3-methoxytyramine (130%) and nonnetanephrine (24%) were 
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observed in the "alcoholic" rat brains compared to controls. It is 
known that DA is found in higher concentration in soluble fractions 
(136) of nerve cells compared to particulate fractiomwhere NE is 
stored (120). Therefore DA would be more susceptible to the action 
of CO!:'IT and would be expected to be more extensively 0-methylated 
than is NE. 
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AcD 
CA 
CNS 
COHT 
DA 
DHPG 
DOPA 
EC/GC 
E 
GC 
HFB-
HCHO 
5-HIAA 
5-IIT 
i.p. 
i.v. 
LRT 
MAO 
MHPG 
NAD 
NADH 
NE 
PFP-
TFA-
THP 
APPENDIX I 
acetaldehyde 
catecholamine 
Central nervous system 
catechol 0-methyltransferase 
dopamine 
3,4-dihydroxyphenylglycol 
3,4-dihydroxyphenylalanine 
electron capture gas chromatography 
epinephrine 
gas chromatogaphy 
heptafluorobutyric-
formaldehyde 
5- hydroxyindole acetic acid 
5- hydroxytriptamine 
intraperitoneal 
intravenous 
long retention time 
monoamine oxidase 
3-methoxy-4-hydroxyphenyl glycol 
nicotinamide adenine dinucleotide 
reduced nicotinamide adenine dinucleotide 
norepinephrine 
pentafluoropropionic-
trifluoroacetic-
tetrahydropapaveroline 
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Appendix I (continued) 
TIQ 
VMA 
1,2,3,4-tetrahydroisoquinoline 
vanillylmandilic acid 
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APPENDIX II 
EFFECT OF ETHANOL ON ADRENAL GLAND PROTEIN AND CA CONCENTRATIONS 
1 Weight of Protein % Drug adrenal Cone. change CA lug/ g ti.S.:'rne) 
Treatment gland(mg) mg/gland prot. DA NE 
from C 
Pyrogallol/ + + 9.7;: 2.0 168 -.t 35 25.7 - 1.0 2.45 - 0.09 
-
saline (6) 
(C) 
+ + 
"/o'; *"'( + ~·d, + Pyrogallol/ 31. 2 - 1. 4"'( 2. 65 - 0 .12 tl.S 12.5 - 3.2 138 - 19 
ethanol (6) 
1 number of rats/group in parenthesis 
* 
** 
\ 
~ 
p 
p 
', 
<:::.:: 0.01 compared to the pyrogallol/saline control 
< 0.05 compared to the pyrogallol/saline control 
-114-
CA (ug/ g protein) 
E DA NE E 
434 ± 41 103 ! 21 1768 ± 180 4557 ± 330 
* 
~·( 
+ ** + 
"k 
224 ~ 39 132 "± 22 1315 - 188 2403 - 410 
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